The Histochemical Journal

, Volume 27, Issue 12, pp 923–964 | Cite as

Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis

  • Frank Dolbeare


This paper follows on from Part 1 of my review of bromodeoxyuridine published earlier this year (Dolbeare, 1995).


Diagnostic Tool Bromodeoxyuridine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdel-Malek,Z. A.,Swope,V. B.,Trinkle,L. S.,Ferroni,E. N.,Boissy,R. E. &Nordlund,J. J. (1988) Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5-bromo-2′-deoxyuridine method of DNA analysis.J. Cell. Physiol. 136, 247–56.PubMedGoogle Scholar
  2. Ackermann,M. F.,Lamm,K. R.,Wiegand,G. W. &Luster,M.I. (1989) Antitumour activity of murine neutrophils demonstrated by cytometric analysis.Cancer Res. 49, 528–32.PubMedGoogle Scholar
  3. Akagi,K. &Tanaka,Y. (1989) Analysis of cell kinetics after gamma ray irradiation using anti-BrdU monoclonal antibody.Nippon Igaku Hoshasen Gakkai Zasshi 49, 477–83.PubMedGoogle Scholar
  4. Akagi,Y.,Ito,K. &Sawada,S. (1993) Radiation-induced apoptosis and necrosis in Molt-4 cells: a study of dose-effect relationships and their modification.Int. J. Radiat. Biol. 64, 47–56.PubMedGoogle Scholar
  5. Akiya,O.,Serizawa,N.,Sugihara,M.,Katagiri,S. &Kawashima,Y. (1992) A histological study of changes in the lingual papillae of streptozotocin-induced diabetic rats.Bull. Tokyo Dent. Coll. 33, 13–24.PubMedGoogle Scholar
  6. Ames,B.N. &Gold,L.S. (1990) Chemical carcinogenesis; too many rodent carcinogens.Proc. Natl. Acad. Sci. USA,87, 7772–6.PubMedGoogle Scholar
  7. Assietti,R.,Butti,G.,Magrassi,L.,Danova,M.,Riccardi,A. &Gaetani,P. (1990) Cell-kinetic characteristics of human brain tumours.Oncology 47, 344–51.PubMedGoogle Scholar
  8. Balazs,M.,Mayall,B. H. &Waldman,F. M. (1991a) Interphase cytogenetics of a male breast cancer.Cancer Genet. Cytogenet. 55, 243–7.PubMedCrossRefGoogle Scholar
  9. Balazs,M.,Mayall,B. H. &Waldman,F. M. (1991b) Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumour cell line.Cancer Genet. Cytogenet. 57, 93–102.PubMedCrossRefGoogle Scholar
  10. Bankert,R. B.,Yokota,S.,Ghosh,S. K.,Mayhew,E. &Jou,Y. H. (1989) Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumourin vitro andin vivo.Cancer Res. 49, 301–8.PubMedGoogle Scholar
  11. Barcellos-Hoff,M. H.,Morton,L. J. &Deen,D. F. (1990) Differential drug sensitivity conferred by growth status detected in a mixed population of cycling and noncycling cells.Cancer Res. 50, 3551–5.PubMedGoogle Scholar
  12. Baril,A.,Boucheron,S.,Dumollard,J. M. &Billard,F. (1990) A quantitative study of epithelial alterations during the early stages of experimental colonic tumourigenesis in mice.Virchows Arch. B. Cell Pathol. 59, 377–82.Google Scholar
  13. Barrass,N. C.,Price,R. J.,Lake,B. G. &Orton,T. C. (1993) Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver.Carcinogenesis 14, 1451–6.PubMedGoogle Scholar
  14. Bartkowiak,D.,Hemmer,J. &Rottinger,E. (1992) Dose dependence of the cytokinetic and cytotoxic effects of epirubicinin vitro.Cancer Chemother. Pharmacol. 30, 189–92.PubMedCrossRefGoogle Scholar
  15. Beauregard,P.,Witzig,T. E.,Kurtin,P. J.,Greipp,P. R.,Stenson,M. J.,Katzmann,J. A.,Habermann,T. M. &Wieand,H. S. (1991) Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labelling index.Hematol. Pathol. 5, 177–83.PubMedGoogle Scholar
  16. Begg,A. C.,Hofland,I.,Moonen,L.,Bartelink,H.,Schraub,S.,Bontemps,P.,LeFur,R.,van denBogaert,W.,Caspers,R.,VanGlabekke,M. &Horiot,J. C. (1990) The predicitive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours.Int. J. Rad. Oncol. Biol. Phys. 19, 1449–53.Google Scholar
  17. Begg,A. C.,Hofland,I.,VanGlabekke,M.,Bartelink,H. &Horiot,J.C. (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results from the Eortc co-operative trial 22851.Seminars Radiat. Oncol. 2, 22–5.Google Scholar
  18. Bendele,A. M.,Stengel,P. W. &Silbaugh,S. A. (1991) Quantitative of bronchiolar epithelial proliferation in A23187-exposed guinea pigs.Agents Actions 34, 194–6.PubMedCrossRefGoogle Scholar
  19. Bendele,A. M.,Hulman,J. F.,White,S.,Brodhecker,C. &Bendele,R. A. (1993) Hepatocellular proliferation in ibuprofen-treated mice.Toxicol. Pathol 21, 15–20.PubMedGoogle Scholar
  20. Bennett,M. H.,Wilson,G. D.,Dische,S.,Saunders,M. I.,Martindale,C. A.,Robinson,B. M.,O'halloran,A. E.,Leslie,M. D. &Laing,J. H. (1992) Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.Br. J. Cancer 65, 870–8.PubMedGoogle Scholar
  21. Bergler,W.,Petroianu,G. &Schadel,A. (1993) Improved antiproliferative effect of cisplatin combined with phorbol ester. Anin vitro study.ORL J. Otorhinolaryngol Relat. Spec. 55, 100–4.PubMedGoogle Scholar
  22. Biasco,G.,Paganelli,G. M.,DiFebo,G.,Siringo,S. &Barbara,L. (1992a) Cell-kinetic alterations induced by aspirin in human gastric mucosa and their prevention by a cytoprotective agent.Digestion 51, 146–51.PubMedGoogle Scholar
  23. Biasco, G., Paganelli, G. M., Psilogenis, M., Nazzari, M., Di, Febo G. &Siringo, S. (1992b) Effect of sulglycotide treatment on cell kinetics alterations induced by aspirin in humans.Agents Actions,C88–9.Google Scholar
  24. Boccadoro,M.,Redoglio,V.,Gavarotti,P. &Pileri,A. (1986) Multiple myeloma plasma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (BrdUrd) DNA incorporation detected by an anti-BrdUrd monoclonal antibody.Tumouri 72, 135–7.Google Scholar
  25. Böhmer,R. M. (1988) Cell cycle position affects response of normal fibroblasts to phorbol esters.Growth Factors 1, 85–90.PubMedGoogle Scholar
  26. Bontenbal,M.,Sieuwerts,A. M.,Klijn,J. G.,Peters,H. A.,Krijnen,H. L.,Sonneveld,P. &Foe Kens,J. A. (1989) Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells.Br. J. Cancer 60, 688–92.PubMedGoogle Scholar
  27. Bontenbal,M.,Sieuwerts,A. M.,Peters,H. A.,Sonneveld,P.,Foekens,J. A. &Klijn,J. G. (1990) Manipulation of cell cycle kinetics: influence on the cytotoxicity of doxorubicin in human breast cancer cells.J. Steroid Biochem. Mol. Biol. 37, 1097–102.PubMedCrossRefGoogle Scholar
  28. Bourhis,J.,Wilson,G.,Wibault,P.,Bosq,J.,Chavaudra,N.,Janot,F.,Luboinski,B.,Eschwege,F. &Malaise,E. P. (1993)In vivo measurement of the potential doubling time by flow-cytometry in oropharyngeal cancer treated by conventional radiotherapy.Int. J. Radiat. Oncol. Biol.Phys. 26, 793–9.PubMedGoogle Scholar
  29. Brito,M. J.,Filipe,M. I. &Morris,R. W. (1992) Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine (BrdU) labelling technique.Eur. J. Cancer Prev. 1, 429–35.PubMedGoogle Scholar
  30. Browman,G. P.,Kanclerz,A.,Booker,L.,Daya,D.,Archibald,S. D.,Young,J. E. &Goldsmith,C. H. (1991) Optimal conditions for immunohistochemical determination of thein vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.Cell Prolif 24, 579–85.PubMedGoogle Scholar
  31. Bruce-Gregorios,J. H.,Soucy,D.,Chen,M. G. &Benson,N. (1991) Effect of methotrexate on cell cycle and DNA synthesis of astrocytes in primary culture: flow cytometric studies.J. Neuropathol Exp. Neurol. 50, 63–72.PubMedGoogle Scholar
  32. Bruno,S.,DiVinci,A.,Geido,E. &Giaretti,W. (1988) Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.Breast Cancer Res. Treat. 11, 221–9.PubMedCrossRefGoogle Scholar
  33. Busse,E.,Zimmer,G. &Kornhuber,B. (1993) Intra-cellular changes of HeLa cells after single or repeated treatment with cytostatics.Arzneimittelforschung 43, 378–81.PubMedGoogle Scholar
  34. Cahill,R. J.,O'sullivan,K. R.,Mathias,P. M.,Beattie,S.,Hamilton,H. &O'morain,C. (1993) Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps.Gut 34, 963–7.PubMedGoogle Scholar
  35. Cameron,R. G. (1989) Identification of the putative first cellular step of chemical hepatocarcinogenesis.Cancer Lett. 47, 163–7.PubMedCrossRefGoogle Scholar
  36. Carboni,P.Jr,Detta,A.,Hitchcock,E. R. &Postans,R. (1992) Pituitary adenoma proliferative indices and risk of recurrence.Br. J. Neurosurg. 6, 33–40.PubMedGoogle Scholar
  37. Carroll,P. R.,Waldman,F. M.,Rosenau,W.,Cohen,M. B.,Vapnek,J. M.,Fong,P.,Narayan,P. &Mayall,B. H. (1993) Cell proliferation in prostatic adenocarcinoma:in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.J. Urol. 149, 403–7.PubMedGoogle Scholar
  38. Char,D. H. (1989) DNA cell cycle studies in uveal melanoma.Trans. Am. Ophthalmol. Soc. 86, 561–80.Google Scholar
  39. Char,D. H.,Crawford,J. B.,Kaleta-Michaels,S.,Howes,E.L.Jr,Lovato,A. A. &Quivey,J. M. (1989a) Analysis of radiation failure after uveal melanoma brachytherapy.Am. J. Ophthalmol. 108, 712–6.PubMedGoogle Scholar
  40. Char,D. H.,Huhta,K. &Waldman,F. (1989b) DNA cell cycle studies in uveal melanoma.Am. J. Ophthalmol. 107, 65–72.PubMedGoogle Scholar
  41. Chatterjee,S.,May,P. L.,Forster,G.,Spiller,D. &Jeffreys,R. V. (1993) Prediction of recurrence in pituitary tumours: a flow cytometric study usingin vivo bromodeoxyuridine.Br. J. Neurosurg.7, 165–9.PubMedGoogle Scholar
  42. Chiba,T. (1993) Cell kinetics of carcinoma originating from rat colitis induced by dextran sulphate sodium.Nippon Shokakibyo Gakkai Zasshi 90, 774–81.PubMedGoogle Scholar
  43. Cho,K. G.,Hoshino,T.,Nagashima,T.,Murovic,J. A. &Wilson,C. B. (1986) Prediction of tumour doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labelling.J. Neurosurg. 65, 790–4.PubMedGoogle Scholar
  44. Cho,K. G.,Hoshino,T.,Pitts,L. H.,Nomura,K. &Shimosato,Y. (1988a) Proliferative potential of brain metastases.Cancer 62, 512–5.PubMedGoogle Scholar
  45. Cho,K. G.,Nagashima,T.,Barnwell,S. &Hoshino,T. (1988b) Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms.J. Neurosurg. 69, 588–92.PubMedGoogle Scholar
  46. Cohen,S.M. &Ellwein,L.B. (1990) Cell proliferation and carcinogenesis.Science,249, 1007–11.PubMedGoogle Scholar
  47. Corvo,R.,Giaretti,W.,Margarino,G.,Danova,M. &Vitale,V. (1991) Thein vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumours of the neck and head. Implications for the radiotherapist.Radiol. Med. (Torino) 82, 147–52.Google Scholar
  48. Corvo,R.,Giaretti,W.,Sanguineti,G.,Geido,E.,Bacigalupo,A.,Franzone,P.,Mereu,P.,Garaventa,G.,Barbieri,M. &Vitale,V. (1993a) The prognostic role of the parameters of cellular kinetics in head and neck tumours treated solely by radiotherapy.Radiol. Med. (Torino 86, 135–42.Google Scholar
  49. Corvo,R.,Giaretti,W.,Sanguineti,G.,Geido,E.,Orecchia,R.,Barra,S.,Margarino,G.,Bacigalupo,A. AndVitale,V. (1993b) Potential doubling time in head and neck tumours treated by primary radiotherapy: Preliminary evidence for prognostic significance in local control.Int. J. Rad. Biol. 27, 1165–72.Google Scholar
  50. Creasey,D. C. &T'so,P. O. (1988) DNA replication in Syrian hamster cells transiently exposed to hydroxyurea.Cancer Res. 48, 6298–308.PubMedGoogle Scholar
  51. Cristov,K.,Chew,K. L.,Ljung,B. M.,Waldman,F. M.,Duarte,L. A.,Goodson,W. H.,Smith,H. S. &Mayall,B. H. (1991) Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.Am. J. Pathol.,138, 1371–7.Google Scholar
  52. D'anna,J.A.,Crissman,H.A.,Jackson,P.J. &Tobey,R. (1985) Time dependent changes in H1 content, H1 turnover, DNA elongation, and the survival of cells blocked in early S phase by hydroxyurea, aphidicolin, or 5-fluorodeoxyuridine.Biochemistry 24, 5020–6.PubMedGoogle Scholar
  53. Danova,M.,Riccardi,A.,Gaetani,P.,Wilson,G. D.,Mazzini,G.,Brugnatelli,S.,Buttini,R.,Butti,G.,Ucci,G.,Paoletti,P. et al. (1988) Cell kinetics of human brain tumours:in vivo study with bromodeoxyuridine and flow cytometry.Eur. J. Cancer Clin. Oncol. 24, 873–80.PubMedCrossRefGoogle Scholar
  54. Danova,M.,Gaetani,P.,Lombardi,M.,Giordano,M.,Riccardi,A. &Mazzini,G. (1991) Prognostic value of DNA ploidy and proliferative activity in human malignant gliomas.Med. Sci. Res. 19, 613–15.Google Scholar
  55. Danova,M.,Pellicciai,C.,Zibera,C.,Mangiarotti,R.,Gibelli,N.,Giordano,M.,Wang,E.,Mazzini,G. &Riccardi,A. (1993) Cell cycle kinetic effects of tamoxifen on human breast cancer cells: Flow cytometric analyses of DNA content, BrdU labelling, Ki-67, PCNA, and statin expression.Ann. N.Y.Acad. Sc. 698, 174–82.Google Scholar
  56. Darmon,E.,Pincu-Hornstein,A. &Rozen,P. (1990) A rapid and simplein vitro method for evaluating human colorectal epithelial proliferation.Arch. Pathol. Lab. Med. 114, 855–7.PubMedGoogle Scholar
  57. Daza,P.,Escalza,P.,Mateos,S. &Cortes,F. (1992) Mitomycin C, 4-nitroquinoline-1-oxide and ethyl methanesulfonate induce long-lived lesions in DNA which result in SCEs during successive cell cycles in human lymphocytes.Mutat. Res. 270, 177–83.PubMedGoogle Scholar
  58. Demarcq,C.,Bastian,G. &Remvikos,Y. (1992) BrdUrd/DNA flow cytometry analysis demonstratescis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.Cytometry 13, 416–22.PubMedCrossRefGoogle Scholar
  59. Detta,A. &Hitchcock,E. (1990) Rapid estimation of the proliferating index of brain tumours.J. Neurooncol. 8, 245–53.PubMedCrossRefGoogle Scholar
  60. Dinda,A. K.,Kharbanda,K.,Sarkar,C.,Roy,S.,Mathur,M. &Banerji,A. K. (1993a)In vivo proliferative potential of primary human brain tumours; its correlation with histological classification and morphological features: I. Gliomas.Pathology 25, 4–9.PubMedGoogle Scholar
  61. Dinda,A. K.,Kharbanda,K.,Sarkar,C.,Roy,S.,Mathur,M. &Banerji,A. K. (1993b)In vivo proliferative potential of primary human brain tumours; its correlation with histological classification and morphological features: II. Nonglial tumours.Pathology 25, 10–14.PubMedGoogle Scholar
  62. Dolbeare,F. (1995) Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part I: Historical perspectives, histochemical methods and cellkinetics.Histochem. J. 27, 339–69.PubMedGoogle Scholar
  63. Dutrillaux,B.,Gerbault-Seureau,M.,Zafrani,B. &Prieur,M. (1991) Prolonged G2 phase of breast cancer cells and chromosome damage.Eur. J. Cancer 27, 1307–12.PubMedGoogle Scholar
  64. Eacho,P. I.,Lanier,T. L. &Brodhecker,C. A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.Carcinogenesis 12, 1557–61.PubMedGoogle Scholar
  65. Eacho,P. I.,Lanier,T. L.,Foxworthy,P. S. &Hoover,D. M. (1992) Effect of the peroxisome proliferator LY171883 on hepatocellular replication in female B6C3F1 mice.Fundam. Appl Toxicol. 18, 632–4.PubMedCrossRefGoogle Scholar
  66. Edstrom,S. S.,Gustafsson,B.,Stenman,G.,Lyden,E.,Stein,H. &Westin,T. (1991) Proliferative pattern of head and neck cancer.Am. J. Surg. 162, 412–6.PubMedCrossRefGoogle Scholar
  67. Ellwart,J. &Dormer,P. (1985) Effect of 5-fluoro-2′-deoxyuridine (FdUrd) on 5-bromo-2′-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.Cytometry 6, 513–20.PubMedCrossRefGoogle Scholar
  68. Fandella,A.,Merlo,F. &DeAngeli,S. (1992) [Effects of mepartricin on the growth of hypertrophic prostatic tissue in primary culture. Creation of the experimental model and preliminary results.]Minerva Urol. Nefrol 44, 15–23.PubMedGoogle Scholar
  69. Fertig,G. &Miltenburger,H. G. (1989) Flow-cytometric cell-cycle analysis of Chinese hamster cells following exposure to cytotoxicants.Mutat. Res. 215, 61–8.PubMedGoogle Scholar
  70. Ffrench,M.,Magaud,J. P.,Arzounian,M.,Souchier,C.,Charrin,C. &Bryon,P. A. (1990) Is there an accumulation of cells during G2 in some acute lymphoblastic leukaemias?Cell Tissue Kinet. 23, 251–60.PubMedGoogle Scholar
  71. Forster,G.,Cooke,T. G.,Cooke,L. D.,Stanton,P. D.,Bowie,G. &Stell,P. M. (1992) Tumour growth rates in squamous carcinoma of the head and neck measured byin vivo bromodeoxyuridine incorporation and flow cytometry.Br. J. Cancer 65, 698–702.PubMedGoogle Scholar
  72. Fowler,J. F. (1986) Potential for increasing the differential response between tumours and normal tissues: Can proliferation rate be used?Int. J. Rad. Oncol. Biol. Phys. 12, 641–5.Google Scholar
  73. Fox,S. B.,Gatter,K. C.,Bicknell,R.,Going,J. J.,Stanton,P.,Cooke,T. G. &Harris,A. L. (1993) Relationship of endothelial cell proliferation to tumour vascularity in human breast cancer.Cancer Res. 53, 4161–3.PubMedGoogle Scholar
  74. Franchini,G.,Tusei,A.,Babilonti,L.,Donadello,N.,Franchi,M.,Zanaboni,F.,Tateo,S.,Mazzini,G.,RaccardiA. &Danova,M. (1994) DNA ploidy and proliferative activity in uterine tumours: anin vivo study using bromodeoxyuridine and flow cytometry.Oncology Reports 1, 65–7.Google Scholar
  75. Frierson,H. F. (1994) Ploidy and proliferative analysis of cytologic specimens. InFlow Cytometry and Clinical Diagnosis (edited byKeren,D. F.,Hanson,C. A. &Hurtubise,P. E.) Chicago: Am. Soc. Clinical Pathologists, Inc.Google Scholar
  76. Fujikane,T.,Shimizu,T.,Tsuji,T.,Ishida,S.,Ohsaki,Y. &Onodera,S. (1989) Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.Cytometry 10, 788–95.PubMedCrossRefGoogle Scholar
  77. Fujimaki,T.,Matsutani,M.,Nakamura,O.,Asai,A.,Funada,N.,Koike,M.,Segawa,H.,Aritake,K.,Fukushima,T.,Houjo,S.,Tamura,A. &Sano,K. (1991) Correlation between bromodeoxyuridine-labelling indices and patient prognosis in cerebral astrocytic tumours of adults.Cancer 67, 629–34.Google Scholar
  78. Fukuda,K.,Iwasaka,T.,Hachisuga,T.,Sugimori,H.,Tsugitomi,H. &Mutoh,F. (1990) Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.Anal. Quant. Cytol. Histol. 12, 135–8.PubMedGoogle Scholar
  79. Fukui,M.,Iwaki,T.,Sawa,H.,Inoue,T.,Takeshita,I. &Kitamura,K. (1986) Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.Acta Neurochir (Wien) 81, 135–41.CrossRefGoogle Scholar
  80. Furlong,J. W. (1994) DNA analysis of breast, lung, central nervous system, endocrine, and head and neck tumours. InFlow Cytometry and Clinical Diagnosis (edited byKeren,D. F.,Hanson,C. A. &Hurtubise,P. E.). Chicago: Am. Soc. Clinical Pathologists, Inc.Google Scholar
  81. Furukawa,F.,Nishikawa,A.,Imaida,K.,Imazawa,T.,Shinoda,K.,Takahashi,M. &Hayashi,Y. (1993) Temporal dissociation between cell proliferation and eosinophilic foci development in the exocrine pancreas of rats initiated with 4-hydroxyaminoquinoline 1-oxide and administered soybean trypsin inhibitor.Carcinogenesis 14, 607–10.PubMedGoogle Scholar
  82. Gaglia,P.,Bernardi,A.,Venesio,T.,Caldarola,B.,Lauro,D.,Cappa,A. P.,Calderini,P. &Liscia,D. S. (1993) Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences [see comments] CM — Comment in:Eur. J. Cancer 1993,29A(11), 1501–2.Eur. J. Cancer 29A, 1509–13.PubMedGoogle Scholar
  83. Garin,L.,Barona,R.,O'Connor,E.,Armengot,M. &Basterra,J. (1991) [Determination of the phase of synthesis by means of bromodeoxyuridine. Its clinical application in oncology of the head and neck.] Determinacion de la fase de sintesis mediante bromodesoxiuridina. Aplicacion clinca en oncologia de cabeza Y cuello.An Otorrinolaringol Ibero Am. 18, 563–74.PubMedGoogle Scholar
  84. Gasinska,A. &Wilson,G. D. (1988) Flow cytometric evaluation of the effects of 2.3 MeV neutrons and 240 kV X-rays on mouse spermatogenic S-phase cells using bromodeoxyuridine incorporation.Br. J. Radiol. 61, 133–9.PubMedGoogle Scholar
  85. Geboes,K.,Nijs,G.,Mengs,U.,Geboes,K. P.,VanDamme,A.,DeWitte,P. (1993) Effects of ‘contact laxatives’ on intestinal and colonic epithelial cell proliferation.Pharmacology 47, (suppl. 1) 187–95.PubMedGoogle Scholar
  86. Genka,S.,Shitara,N.,Tsujita,Y.,Kosugi,Y. &Takakura,K. (1988) Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.J. Neurooncol. 6, 299–307.PubMedCrossRefGoogle Scholar
  87. Gerlyng,P.,Grotmol,T.,Erikstein,B.,Stokke,T. &Seglen,P. O. (1992) Reduced proliferative activity of polyploid cells in primary hepatocellular carcinoma.Carcinogenesis 13, 1795–802.PubMedGoogle Scholar
  88. Giaretti,W. (1991) Ploidy and proliferation evaluated by flow cytometry. An overview of techniques and impact in oncology.Tumouri 77, 403–19.Google Scholar
  89. Giles,R. E.,Boyce,F. M. &Brockman,W. W. (1991) Evaluation of the mutagenic effects of SV40 in mouse, hamster, and mouse-human hybrid cells.Somat. Cell Mol. Genet. 17, 327–39.PubMedCrossRefGoogle Scholar
  90. Gillette,D. M. &Frederick,C. B. (1993) Quantitation of an epithelial S-phase response in the rat forestomach and glandular stomach following gavage dosing with ethyl acrylate.Toxicol. Appl. Pharmacol. 122, 244–57.PubMedCrossRefGoogle Scholar
  91. Giordano,M.,Riccardi,A.,Danova,M.,Brugnatelli,S. &Mazzini,G. (1991a) Cell proliferation of human leukemia and solid tumours studied within vivo bromodeoxyuridine and flow cytometry.Cancer Detect. Prev. 15, 391–6.PubMedGoogle Scholar
  92. Giordano,M.,Riccardi,A.,Girino,M.,Brugnatelli,S.,Scivetti,P.,Luoni,R. et al. (1991b) Postremission chemotherapy in adult acute non-lymphoblastic leukemia including intensive or non-intensive consolidation therapy.Eur. J. Cancer 4, 437–41.Google Scholar
  93. Giordano,M.,Danova,M.,Mazzini,G.,Gobbi,P. &Riccardi,A. (1993) Cell kinetics within vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia.Cancer 71, 2739–45.PubMedGoogle Scholar
  94. Girino,M.,Riccardi,A.,Danova,M.,Gaetani,P.,Butti,G.,Giordano,M. &Cuomo,A. (1990) Immunocytochemical evaluation of proliferative activity in human brain tumours.Anal. Cell Pathol. 2, 269–75.PubMedGoogle Scholar
  95. Girino,M.,Riccardi,A.,Luoni,R.,Ucci,G. &Cuomo,A. (1991) Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.Acta Haematol. 85, 26–30.PubMedGoogle Scholar
  96. Going,J. J.,Stanton,P. D. &Cooke,T. G. (1993) Influences on measurement of cellular proliferation by histology and flow cytometry in mammary carcinomas labelledin vivo with bromodeoxyuridine.Am. J. Clin. Pathol. 100, 218–22.PubMedGoogle Scholar
  97. Goodson,W. H.,Ljung,B. M.,Waldman,F.,Mayall,B.,Chew,K.,Moore,D. H.,Smith,H.,Goldman,E. S. &Benz,C. (1991)In vivo measurement of breast cancer growth rate.Arch. Surg. 126, 1220–3; discussion 1.PubMedGoogle Scholar
  98. Goodson,W.H.,Ljung,B. M.,Moore,D. H.,Mayall,B.,Waldman,F. M.,Chew,K.,Benz,C. C. &Smith,H. S. (1993) Tumour labelling indices of primary breast cancers and their regional lymph node metastases.Cancer 71, 3914–9.PubMedGoogle Scholar
  99. Haftek,M.,Urabe,A.,Kanitakis,J.,Dusserre,N. &Thivolet,J. (1990–91) Cyclosporin A inhibits DNA synthesis by epidermal Langerhans cells.Reg. Immunol. 3, 236–41.Google Scholar
  100. Hagiwara,A.,Asakawa,E.,Kurata,Y.,Sano,M.,Hirose,M. &Ito,N. (1992) Dose-dependent renal tubular toxicity of harman and norharman in male F344 rats.Toxicol. Pathol. 20, 197–204.PubMedGoogle Scholar
  101. Hammann,A.,Arveux,P. &Martin,M. (1992) Effect of gut-associated lymphoid tissue on cellular proliferation in proximal and distal colon of the rat.Dig. Dis. Sci. 37, 1099–105.PubMedCrossRefGoogle Scholar
  102. Hardonk,M. J. &Harms,G. (1990) The use of 5′-bromodeoxyuridine in the study of cell proliferation.Acta Histochem. Suppl 39, 99–108.PubMedGoogle Scholar
  103. Hasegawa,N.,Kawamoto,K. &Uemura,T. (1992) Studies on antitumour effects and mechanism of action of 1-hexylcarbamoyl-5-fluorouracil by DNA/BrdU double staining using flow cytometry.Hum. Cell 5, 167–73.PubMedGoogle Scholar
  104. Hashimoto,H.,Sasaki,M.,Fujisawa,M.,Kaneko,S.,Tokunaka,S. &Yachiku,S. (1990) [The changes of population and distribution of S-phase cells in precancerous lesions of rat bladder revealed by the method of bromodeoxyuridine labelling.]Nippon Hinyokika Gakkai Zasshi 81, 1518–24.PubMedGoogle Scholar
  105. Hauser,K. F. (1992) Morphine regulates DNA synthesis in rat cerebellar neuroblastsin vitro.Brain Res. Dev. Brain Res. 70, 291–7.PubMedGoogle Scholar
  106. Hayashi,Y.,Fukayama,M.,Koike,M.,Kaseda,S.,Ikeda,T. &Yokoyama,T. (1993) Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labelling and an application to lung tumours.Acta Pathol. Jpn. 43, 313–19.PubMedGoogle Scholar
  107. Hemmer,J. (1990a)In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity.Eur. J. Cancer 26, 113–15.PubMedGoogle Scholar
  108. Hemmer,J. (1990b) Rapidin vitro bromodeoxyuridine labelling method for monitoring of therapy response in solid human tumours.Cytometry 11, 603–9.PubMedCrossRefGoogle Scholar
  109. Henderson,R. F.,Hotchkiss,J. A.,Chang,I. Y.,Scott,B. R. &Harkema,J. R. (1993) Effect of cumulative exposure on nasal response to ozone.Toxicol. Appl. Pharmacol. 119, 59–65.PubMedCrossRefGoogle Scholar
  110. Hiasa,Y.,Konishi,N.,Nakaoka,S.,Nakamura,T.,Nishii,K. &Ohshima,M. (1992) Promoting effects of potassium dibasic phosphate on early-stage renal carcinogenesis in unilaterally nephrectomized rats treated withN-ethyl-N-hydroxyethylnitrosamine.Jpn. J. Cancer Res. 83, 688–94.PubMedGoogle Scholar
  111. Hieber,L.,Beck,H. P. &Lucke Huhle, C. (1981) G2-delay after irradiation with alpha-particles as studied in synchronized cultures and by the bromodeoxyuridine-33258H technique.Cytometry 2, 175–8.PubMedCrossRefGoogle Scholar
  112. Higashikubo,R.,White,R. A. &Roti RotiJ.L. (1993) Flow cytometric BrdUrd-pulse-chase study of heat-induced cell-cycle progression delays.Cell Prolif 26, 337–48.PubMedGoogle Scholar
  113. Hirai,R.,Oguchi,Y.,Sugita,N.,Matsunaga,K. &Nomoto,K. (1993) Enhancement of T-cell proliferation by PSK.Int. J. Immunopharmacol. 15, 745–50.PubMedCrossRefGoogle Scholar
  114. Hoffman,B.D.,Hanauske-Abel,H.M.,Flint,A. &Lalande,M. (1991) A new class of reversible cell cycle inhibitors.Cytometry 12, 26–32.PubMedCrossRefGoogle Scholar
  115. Holland,J. F.,Bruckner,H. W.,Cohen,C. J.,Wallach,R. C.,Gusberg, S. B.,Greenspan,E. M. &Goldberg,J. (1980) Cisplatin therapy of ovarian cancer. InCisplatin: Current Status and New Developments (edited byPrestayko,A. w.,Crooke,S. T. &Carter, S. K.), pp. 383–402. New York: Academic Press.Google Scholar
  116. HornbyS. B. &Kellington,J. P. (1990) DNA Synthesis in alveolar macrophages and other changes in lavaged cells following exposure of CBA/H mice to cigarette smoke.Environ. Health Perspect. 85, 107–12.PubMedGoogle Scholar
  117. Hoshino,T. (1992) Cell kinetics of glial tumours.Rev. Neurol. (Paris) 148, 396–401.Google Scholar
  118. Hoshino,T.,Nagashima,T.,Murovic,J.,Levin,E. M.,Levin,V. A. &Rupp,S. M. (1985) Cell kinetic studies ofin situ human brain tumours with bromodeoxyuridine.Cytometry 6, 627–32.PubMedCrossRefGoogle Scholar
  119. Hoshino,T.,Nagashima,T.,Cho,K. G.,Murovic,J. A.,Hodes,J. E.,Wilson,C. B.,Edwards,M. S. &Pitts,L. H. (1986a) S-phase fraction of human brain tumoursin situ measured by uptake of bromodeoxyuridine.Int. J. Cancer 38, 369–74.PubMedGoogle Scholar
  120. Hoshino,T.,Nagashima,T.,Murovic,J. A.,Wilson,C. B. &Davis,R. L. (1986b) Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.Cancer 58, 1466–72.PubMedGoogle Scholar
  121. Hoshino,T.,Rodriguez,L. A.,Cho,K. G.,Lee,K. S.,Wilson,C. B.,Edwards,M. S.,Levin,V. A. &Davis,R. L. (1988) Prognostic implications of the proliferative potential of low-grade astrocytomas.J. Neurosurg. 69, 839–42.PubMedGoogle Scholar
  122. Hoshino,T.,Nagashima,T.,Cho,K. G.,Davis,R. L.,Donegan,J.,Slusarz,M. &Wilson,C. B. (1989a) Variability in the proliferative potential of human gliomas.J. Neurooncol. 7, 137–43.PubMedCrossRefGoogle Scholar
  123. Hoshino,T.,Prados,M.,Wilson,C. B.,Cho,K. G.,Lee,K. S. &Davis,R. L. (1989b) Prognostic implications of the bromodeoxyuridine labelling index of human gliomas.J. Neurosurg. 71, 335–41.PubMedGoogle Scholar
  124. Hoshino,T.,Ahn,D.,Prados,M. D.,Lamborn,K. &Wilson,C. B. (1993) Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labelling.Int. J. Cancer 53, 550–5.PubMedGoogle Scholar
  125. Huang,Y.,Chang,C. C. &Trosko,J. E. (1983) Aphidicolin-induced endoreduplication in Chinese hamster cells.Cancer Res. 43, 1361–4.PubMedGoogle Scholar
  126. Huitfeldt,H. S.,Brandtzaeg,P. &Poirier,M. C. (1990) Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen.Proc. Natl Acad. Sci. USA 87, 5955–8.PubMedGoogle Scholar
  127. Ikeda,H. &Yoshimoto,T. (1992) The relationship between c-myc protein expression, the bromodeoxyuridine labelling index and the biological behavior of pituitary adenomas.Acta Neuropathol (Berl.) 83, 361–4.Google Scholar
  128. Imai,T.,Kobayasi,S.,Rodrigues,M. A.,DeCamargo,J.L.,Ogawa,K.,Iwata,H. &Tatematsu,M. (1993) Reduction of cell proliferative activities of gastric stump adenomatous hyperplasias after bile reflux diversion in rats.Carcinogenesis 14, 1765–9.PubMedGoogle Scholar
  129. Inoue,S. &Mizuno,S. (1992) The theory of flow cytometric analysis of the cell cycle and their applications in biology and oncology.Nippon Rinsho 50, 2324–32.PubMedGoogle Scholar
  130. Inoue,S.,Mizuno,S.,Ito,M. &Ohnuma,T. (1992) Flow cytometric analyses of the characteristics of tumour cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)-platinum(II) and cisplatin.Jpn. J. Cancer Res.83, 1231–40.PubMedGoogle Scholar
  131. Inoue,T.,Tashima,T.,Nishio,S.,Takeshita,I.,Iwaki,T. &Fukui,M. (1988) Vascular permeability and cell kinetics of ethylnitrosourea (ENU)-induced rat brain tumours.Acta Neurochir. (Wien) 91, 67–72.CrossRefGoogle Scholar
  132. Inuyama,Y.,Fujii,M. &Tanaka,J. (1985) Neoadjuvant chemotherapy in maxillary sinus carcinoma with cisplatin and peplomycin intraarterial infusion.Auris Nasus Larynx 12 (Suppl II), 249–54.Google Scholar
  133. Isetani,K.,Hosokawa,Y.,Wakabayashi,N.,Tokita,K.,Mitsufuji,S.,Maruyama,K.,Kodama,T.,Kashima,K.,Tsuchihashi,Y. (1993) [Analysis of proliferative activity in gastric biopsy specimens by combined BrdU and DNA polymerase alpha immunohistochemistry.]Nippon Shokakibyo Gakkai Zasshi 90, 91–6.PubMedGoogle Scholar
  134. Ito,H.,Kamiryo,T.,Kajiwara,K.,Nishizaki,T. &Oshita,N. (1990) [Malignancy of brain tumours.]No Shinkei Geka 18, 595–9.PubMedGoogle Scholar
  135. Ito,S.,Hoshino,T.,Prados,M. D. &Edwards,M. S. (1992a) Cell kinetics of medulloblastomas.Cancer 70, 671–8.PubMedGoogle Scholar
  136. Ito,S.,Hoshino,T.,Shibuya,M.,Prados,M. D.,Edwards,M. S. &Davis,R. L. (1992b) Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labelling.Neurosurgery 31, 413–18; discussion 419.PubMedGoogle Scholar
  137. Itoh,T.,Yamamoto,Y.,Saka,T.,Inoue,I. &Takahashi,H. (1993) Estimation of proliferative activity of experimental tongue carcinoma in rats. Immunohistochemical and DNA cytofluorometric analysis.Acta Otolaryngol. (Stockh) 113, 568–74.Google Scholar
  138. Izumoto,S.,Arita,N.,Ushio,Y.,Hayakawa,T.,Yoshimine,T.,Tzuu-Yuan,H.,Nagatani,M.,Oku,Y. &Mogami,H. (1988) [Effect of ACNU against experimental brain tumour immunohistochemical study using anti-BrdU monoclonal antibody]NoTo Shinkei 40, 1095–9.Google Scholar
  139. Izutsu,T.,Hirama,T.,Matsuda,M.,Yoshizumi,N.,Kagabu,T. &Nishiya,I. (1989) [Cell kinetic effects ofcisplatinum on cancer cells in a culture system and in cases of cervical cancer using monoclonal antibody of BrdU.]Gan To Kagaku Ryoho 16, 1834–41.PubMedGoogle Scholar
  140. Jacoby,R. F.,Bolt,M. J.,Dolan,M. E.,Otto,G.,Dudeja,P.,Sitrin,M. D. &Brasitus,T. A. (1993) Supplemental dietary calcium fails to alter the acute effects of1, 2-dimethylhydrazine onO6-methylguanine,O6-alkylguanine-DNA alkyItransferase and cellular proliferation in the rat colon.Carcinogenesis 14, 1175–9.PubMedGoogle Scholar
  141. Janus,T. J.,Kim,E. E.,Tilbury,R.,Bruner,J. M.,Yung, W. K. (1993) Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumours.Ann. Neurol. 33, 540–8.PubMedCrossRefGoogle Scholar
  142. Johannisson,A.,Eriksson,B.,Amneus,H. &Zetterberg,G. (1992) Attempts to use the HPRT-assay as an automated short-term monitor for an acute exposure to mutagens.Cell Biol. Toxicol. 8, 233–53.PubMedCrossRefGoogle Scholar
  143. Jones,H. B.,Clarke,N. A. &Barrass,N. C. (1993) Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry.J. Histochem. Cytochem. 41, 21–7.PubMedGoogle Scholar
  144. Jung-Rou,T. (1989) [Biological activity of hepatocellular carcinoma by analysing nuclear DNA ploidy patterns and using anti BrdU monoclonal antibody.]Nippon Geka Gakkai Zasshi 90, 168–80.PubMedGoogle Scholar
  145. Kaku,T.,Ohuchi,T.,Nakade,O.,Ogawa,A.,Kanno,H.,Abe,H. &Okuyama,T. (1989) Patterns of epithelial proliferation revealed by intraperitoneal administration of bromodeoxyuridine during buccal pouch carcinogenesis in hamsters.Shika Kiso Igakkai Zasshi 31, 749–52.PubMedGoogle Scholar
  146. Kaleta-Michaels,S.,Char,D. H.,Kroll,S. M. &Waldman,F. M. (1991) Retinoblastoma cell cycling.Cytometry 12, 188–92.PubMedCrossRefGoogle Scholar
  147. Kamata,Yonemura,Y.,Sugiyama,K.,Ooyama,S.,Kosaka,T.,Yamaguchi,A.,Miwa,K. &Miyasazi,I. (1989) Proliferative activity of early gastric cancer measured byin vitro andin vivo bromodeoxyuridine labelling.Cancer 64, 1665–8.PubMedGoogle Scholar
  148. Kamata,T.,Yonemura,Y.,Oyama, S.,Sugiyama,K.,Kosaka,T.,Miwa,K. &Miyazaki,I. (1990) [Malignancy in gastric cancer, with special reference to the distribution of BrdU-labelled cells].Nippon Geka Gakkai Zasshi 91, 335–9.PubMedGoogle Scholar
  149. Katano,N.,Tsurusawa,M.,Niwa,M. &Fujimoto,T. (1989) Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of Sphase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.Am. J. Pediatr. Hematol. Oncol. 11, 411–6.PubMedGoogle Scholar
  150. Kataoka,M.,Akagi,K.,Kobayashi,K.,Ooyama,A. &Tanaka,Y. (1990) [Analysis of cell kinetics using BrdU monoclonal antibody on cultured tumour cells after irradiation and treatment with anti-cancer drugs.]Hum. Cell 3, 45–51.PubMedGoogle Scholar
  151. Katayanagi,N. (1990) [An experimental study of anti-cancer agent sensitivity test in human gastric cancer cell lines by flow cytometry].Nippon Geka Gakkai Zasshi 91, 827–36.PubMedGoogle Scholar
  152. Katayanagi,N.,Suzuki,T.,Tanaka,O. &Muto, T. (1992) [Flow cytometric BrdU/DNA assay for anti-cancer agent sensitivity test.]Nippon Rinsho 50, 2386–90.PubMedGoogle Scholar
  153. Kato,M.,Popp,J. A.,Conolly,R. B. &Cattley,R. C. (1993) Relationship between hepatocyte necrosis, proliferation, and initiation induced by diethylnitrosamine in the male F344 rat.Fundam. Appl. Toxicol. 20, 155–62.PubMedCrossRefGoogle Scholar
  154. Kawamoto,K.,Wada,Y.,Kumazawa,H.,Yamashita,T.,Kumazawa,T. &Matsumura,H. (1992) Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).Cytometry 13, 307–13.PubMedCrossRefGoogle Scholar
  155. Kawaoi,A.,Matsumoto,H.,Suzuki,K. &Moriyama,S. (1991) Histogenesis of diisopropanolnitrosamine (DIPN)-induced tumours of the rat thyroid gland.Virchows Arch. B. Cell Pathol. 61, 49–56.Google Scholar
  156. Kawauchi,K.,Sato,Y.,Furuya,T. &Watanabe,S. (1989) Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomas.Hematol. Oncol. 7, 257–65.PubMedGoogle Scholar
  157. Khan,S.,Raza,A.,Petrelli,N. &Mittleman,A. (1988) In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonic mucosa using intravenous infusions of bromodeoxyuridine.J. Surg. Oncol. 39, 114–18.PubMedGoogle Scholar
  158. Khinev,S.,Georgieva,V.,Dafinova,E. &Pukhtova,B. (1993) [Changes in the cell cycle of cultured lymphocytes from patients subjected to halothane anesthesia.]Khirurgiia (Sofiia) 46, 10–12.Google Scholar
  159. Kikuchi,N.,Yamaguchi,Y.,Mori,K.,Takata,N.,Goto,M.,Makino,Y.,Hamaguchi,H.,Hisama,N. &Ogawa,M. (1993) Effect of cyclosporine on liver regeneration after orthotopic reduced-size hepatic transplantation in the rat.Dig. Dis. Sci. 38, 1492–9.PubMedCrossRefGoogle Scholar
  160. Kikuyama,S. (1989) [Cell kinetic study of human carcinomas using bromodeoxyuridine and immunohistochemistry.]Nippon Geka Gakkai Zasshi 90, 355–63.PubMedGoogle Scholar
  161. Kikuyama,S.,Kubota,T.,Watanabe,M.,Ishibiki,K. &Abe,O. (1988) Cell kinetic study of human carcinomas using bromodeoxyuridine.Cell Tissue Kinet. 21, 15–20.PubMedGoogle Scholar
  162. Kinami,Y.,Ashida,Y.,Gotoda,H.,Seto,K.,Kojima,Y. &Takashima,S. (1993) Promoting effects of bile acid load on the occurrence of cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters.Oncology 50, 46–51.PubMedGoogle Scholar
  163. Kindy-Degnan,N.,Char,D. H.,Swift,P.,Kaleta,S. &Ljung,B. M. (1989) Bromodeoxyuridine uptake in the assessment of hyperthermic therapy for intraocular tumour.Arch. Ophthalmol. 107, 746–50.PubMedGoogle Scholar
  164. Kirillova,T. V.,Rozanov,I.U.M. &Spivak,I. M. (1992) [The effect of 3-aminobenzamide on the mitotic cycle of Chinese hamster cells cultured on a medium with 5-bromodeoxyuridine following ionizing radiation action.]Tsitologiia 34, 76–81.PubMedGoogle Scholar
  165. Kirkhus,B.,Olsen,W. M. &Clausen,O. P. (1991) A comparison between the epidermal regenerative responses provoked by a skin irritant and a tumour promoter using anti-BrdUrd/DNA flow cytometry.Carcinogenesis 12, 833–7.PubMedGoogle Scholar
  166. Kitano,M.,Hatano,H. &Shisa,H. (1992) Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats.Jpn. J. Cancer Res. 83, 843–50.PubMedGoogle Scholar
  167. Kleibeuker,J. H.,Welberg,J. W.,Mulder,N. H.,van derMeer,R.,Cats,A.,Limburg,A. J.,Kreumer,W. M.,Hardonk,M. J. &DeVries,E.G. (1993) Epithelial cell proliferation in the sigmoid colon of patients with adenomatous polyps increases during oral calcium supplementation.Br. J. Cancer 67, 500–3.PubMedGoogle Scholar
  168. Kotecki,M.,Pawlak,A. L. &Wiktorowicz,K. E. (1989) The inhibitory effect of theophylline on cell cycle kinetics of human vitro.Arch. Immunol. Ther. Exp. (Warsz.) 37, 725–33.Google Scholar
  169. Koza,R. A.,Moore,M. J. &Stegeman,J. J. (1993) Elevated ornithine decarboxylase activity, polyamines and cell proliferation in neoplastic and vacuolated liver cells of winter flounder. (Pleuronectes americanus).Carcinogenesis 14, 399–405.PubMedGoogle Scholar
  170. Kruse,F. E. &Tseng,S. C. (1993) A tumour promoter-resistant subpopulation of progenitor cells is larger in limbal epithelium than in corneal epithelium.Invest. Ophthalmol. Vis Sci. 34, 2501–11.PubMedGoogle Scholar
  171. Ku,W. W.,Shih,L. M.,Chapin,R. E. (1993) The effects of boric acid (BA) on testicular cells in culture [see comments] CM — Comment in:Reprod. Toxicol. 1993 Jul–Aug; 7(4): 295–6.Reprod. Toxicol. 7, 321–31.Google Scholar
  172. Kubbies,M.,Goller,B.,Schetters,B.,Bar-Tosek,I. &Albert,W. (1991) Glutathione restores normal cell activation and cell cycle progression in cis-platinum treated human lymphocytes.Br. J. Cancer 64, 843–9.PubMedGoogle Scholar
  173. Kudo,H.,Sakamoto,S.,Suzuki,S.,Kuwa,K.,Nakayama,T.,Sugiura,Y.,Kasahara,N.,Tomiyama,J. &Adachi,Y. (1992) Thermal effects on DNA synthesis in bone marrow cells of patients with acute myeloblastic leukemia.Anticancer Res. 12, 1543–7.PubMedGoogle Scholar
  174. Kusaba,Y. (1992) [Clinicopathological study on the proliferation and differentiation of laryngeal carcinoma and dysplasia.]Fukuoka Igaku Zasshi 83, 426–33.PubMedGoogle Scholar
  175. Koza,R. A.,Moore,M. J. &Stegeman,J. J. (1993) Elevated ornithine decarboxylase activity, polyamines and cell proliferation in neoplastic and vacuolated liver cells of winter flounder (Pleuronectes americanus).Carcinogenesis 14, 399–405.PubMedGoogle Scholar
  176. Kusewitt,D. F.,Budge,C. L.,Nolla,H. A.,Edwards,B. S. &Ley,R. D. (1992) Cell cycle progression in denV-transfected murine fibroblasts exposed to ultraviolet radiation.Mutat. Res. 274, 163–76.PubMedGoogle Scholar
  177. Labrousse,F.,Daumas-Duport,C.,Batorski,L. &Hoshino,T. (1991) Histological grading and bromodeoxyuridine labelling index of astrocytomas. Comparative study in a series of 60 cases.J. Neurosurg. 75, 202–5.PubMedGoogle Scholar
  178. Lacombe,F.,Belloc,F.,Dumain,P.,Puntous,M.,Lopez,F.,Bernard,P.,Boisseau,M. &Reiffers,J. (1992) Quantitation of resistance to cytosine arabinoside from BrdUrd/DNA bivariate histograms.Cytometry 13, 730–8.PubMedCrossRefGoogle Scholar
  179. Langer,E. M.,Hemmer,J.,Kleinhans,G. &Gohde,W. (1988) The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma.Urol. Res. 16, 303–7.PubMedCrossRefGoogle Scholar
  180. Lanier,T. L.,Berger,E. K. &Eacho,P. I. (1989) Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents.Carcinogenesis 10, 1341–3.PubMedGoogle Scholar
  181. Lee,K. P.,Valentine,R. &Bogdanffy,M. S. (1992) Nasal lesion development and reversibility in rats exposed to aerosols of dibasic esters.Toxicol. Pathol. 20, 376–93.PubMedGoogle Scholar
  182. Lee,K. S.,Hoshino,T.,Rodriguez,L. A.,Bederson,J.,Davis,R. L. &Wilson,C. B. (1990) Bromodeoxyuridine labelling study of intracranial meningiomas: proliferative potential and recurrence.Acta Neuropathol (Berl.) 80, 311–17.CrossRefGoogle Scholar
  183. Lelande,M. (1990) A reversible arrest point in the late G1 phase of the mammalian cell cyce.Exp. Cell Res. 186, 332–9.Google Scholar
  184. Liebmann,J. E.,Hahn,S. M.,Cook,J. A.,Lipschultz,C.,Mitchell,J. B. &Kaufman,D. C. (1993) Glutathione depletion byl-buthionine sulfoximine antagonizes taxol cytotoxicity.Cancer Res. 53, 2066–70.PubMedGoogle Scholar
  185. Limas,C.,Bigler,A.,Bair,R.,Bernhart,P. &Reddy,P. (1993) Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.J. Clin. Pathol. 46, 159–65.PubMedGoogle Scholar
  186. Lloveras,B.,Edgerton,S. &Thor,A. D. (1991) Evaluation ofin vitro bromodeoxyuridine labelling of breast carcinomas with the use of a commercial kit.Am. J. Clin. Pathol. 95, 41–7.PubMedGoogle Scholar
  187. Loury,D. J.,Goldsworthy,T.L. &Butterworth,B.E. (1987) The value of measuring cell proliferation as a predictive index of tissue specific tumourogenic potential. InNongenotoxic Mechanisms in Carcinogenesis (edited byButterworth,B.E. &Slaga,T. J.) pp. 119–36. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.Google Scholar
  188. Lutzow-Holm,C.,De,AngelisP. &Clausen,O.P. (1992) Retinoic acid provokes a regeneration-like proliferative response in murine epidermis. A bivariate DNA/bromodeoxyuridine flow cytometric study.Arch. Dermatol. Res. 284, 418–23.PubMedGoogle Scholar
  189. Mack,E. E. &Wilson,C. B. (1993) Meningiomas induced by high-dose cranial irradiation.J. Neurosurg. 79, 28–31.PubMedGoogle Scholar
  190. Mcnally,N. J. (1989) Can cell kinetic parameters predict the response of tumours to radiotherapy?Int. J. Radiat. Biol. 56, 777–86.PubMedGoogle Scholar
  191. Maeda,T. &Hoshino,T. (1992) [Proliferation kinetics of human brain tumours byin situ double labelling with bromodeoxyuridine and iododeoxyuridine.]No To Shinkei 44, 821–5.PubMedGoogle Scholar
  192. Mancini,R.,Jezequel,A. M.,Benedetti,A.,Paolucci,F.,Trozzi,L. &Orlandi,F. (1992) quantitative analysis of proliferating sinusoidal cells in dimethylmtrosamine-induced cirrhosis. An immunohistochemical study.J. Hepatol 15, 361–6.PubMedCrossRefGoogle Scholar
  193. Manson,M. M.,Green,J. A.,Wright,B. J. &Carthew,P. (1992) Degree of ethoxyquin-induced nephrotoxicity in the rat is dependent on age and sex.Arch. Toxicol. 66, 51–6.PubMedCrossRefGoogle Scholar
  194. March,K. L.,Wilensky,R. L.,Roeske,R. W. &Hathaway,D. R. (1993) Effects of thiol protease inhibitors on cell cycle and proliferation of vascular smooth muscle cells in culture.Circ. Res. 72, 413–23.PubMedGoogle Scholar
  195. Margarino,G.,Scala,M.,Schenone,G.,Mereu,P.,Corvo,R.,Sanguineti,G.,Giaretti,W.,Geido,E.,Orecchia,R.,Meszaros,P. et al. (1992) [Cell kinetic analysis and treatment planning in epidermoid tumours of the head and neck.]Acta Otorhinolaryngol Ital. 12, 421–33.PubMedGoogle Scholar
  196. Mariya,Y.,Aoki,M.,Tarusawa,N.,Takekawa,S.,Kaimori,M. &Abe,Y. (1993) [Determination of potential doubling time usingin vitro continuous labelling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma.]Nippon Igaku Hoshasen Gakkai Zasshi 53, 976–8.PubMedGoogle Scholar
  197. Mark,M. P.,Bloch-Zupan,A. &Ruch,J. V. (1992) Effects of retinoids on tooth morphogenesis and cytodifferentiation.Int. J. Dev. Biol. 36, 517–26.PubMedGoogle Scholar
  198. Marshall,M. J.,Holt,I.,Davie,M. W. (1993) Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate.Calcif. Tissue Int. 52, 21–5.PubMedCrossRefGoogle Scholar
  199. Maruno,K.,Yamaguchi,K.,Abe,K.,Suzuki,M.,Saijo,N.,Mishima,Y.,Yanaihara,N. &Shimosato,Y. (1989) Immmunoreactive gastrin-releasing peptide as a specific tumour marker in patients with small cell lung carcinoma.Cancer Res. 49, 629–32.PubMedGoogle Scholar
  200. Mashiba,H.,Matsunaga,K.,Yagawa,K.,Nomura,Y.,Yoshinaga,H.,Furusawa,M. &Jimi,S. (1981) Elevated cytostatic activity of monocytes from cancer patients.Gann 72, 848–53.PubMedGoogle Scholar
  201. Matsson,P.,Amnéus,H.,Djupsjobacka,M.,Eriksson,B.,Eriksson,L.,Fellner-Feldegg,H. &Zetterberg,G. (1985) Direct and indirect flow cytometric enumeration of 6-thioguanine-resistant human peripheral blood lymphocytes.Cytometry 6, 648–56.PubMedCrossRefGoogle Scholar
  202. Matsubara,M.,Sakai,M.,Yamagami,K.,Kitazawa,Y.,Kawamoto,K. &Tanaka,T. (1992) [The influence of paraquat on cell cycle — analysis of cell kinetics using DNA/BrdU staining.]Hum. Cell 5, 372–6.PubMedGoogle Scholar
  203. Matsumoto,H. &Sasaki,Y. (1989) Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells.Biochem. Biophys. Res. Commun. 158, 105–9.PubMedCrossRefGoogle Scholar
  204. Matsumoto,M.,Takagi,H. &Yoshimura,N. (1993) Synergistic suppression of retinal pigment epithelial cell proliferation in culture by radiation and hyperthermia.Invest. Ophthalmol. Vis. Sci. 34, 2068–73.PubMedGoogle Scholar
  205. Matsunaga,S.,Ijiri,K.,Sakou,T. &Morimoto,N. (1993) Immunohistochemical study of activating osteoblasts from undifferentiated mesenchymal cells by electrical stimulation.Bone 14, 327–32.PubMedCrossRefGoogle Scholar
  206. Maybaum,J.,Burton,E. C.,Shelton,D. A.,Jing,H. W.,Dusenbury,C. E.,Ensminger,W. D. &Stetson,P. L. (1991) Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumour cell lines.Biochem. Pharmacol 42, 131–7.PubMedCrossRefGoogle Scholar
  207. Mayol,X.,Neal,G. E.,Davies,R.,Romero,A. &Domingo,J. (1992) Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes.Carcinogenesis 13, 2381–8.PubMedGoogle Scholar
  208. Meyer,J. S.,Koehm,S. L.,Hughes,J. M.,Higa,E.,Wittliff,J. L.,Lagos,J. A. &Manes,J. L. (1993) Bromodeoxyuridine labelling for S-phase measurement in breast carcinoma.Cancer 71, 3531–40.PubMedGoogle Scholar
  209. Miller,M. A.,Mazewski,C. M.,Yousuf,N.,Sheikh,Y.,White,L. M.,Yanik,G. A.,Hyams,D. M.,Lampkin,B. C. &Raza,A. (1991) Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.J. Histochem. Cytochem. 39, 407–12.PubMedGoogle Scholar
  210. Miller,M. W. (1992) Circadian rhythym of cell proliferation in the telencephalic ventricular zone: effect ofin utero exposure to ethanol.Brain Res. 595, 17–24.PubMedCrossRefGoogle Scholar
  211. Minagawa,Y.,Kigawa,J.,Kanamori,Y.,Itamochi,H. &Terakawa,N. (1993) Tumour cell kinetics in elderly patients with cervical cancer.Obstet. Gynecol. 81, 610–14.PubMedGoogle Scholar
  212. Mineura,K.,Watanabe,K.,Izumi,I. &Kowada,M. (1992) Modulation of BUdR labelling index in rat brain tumours following intracarotid ACNU administration.J. Neurooncol. 14, 201–5.PubMedCrossRefGoogle Scholar
  213. Miyagami,M.,Tazoe,M.,Kasahara,E. &Tsubokawa,T. (1989) [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma.]Gan To Kagaku Ryoho 16, 2059–65.PubMedGoogle Scholar
  214. Miyamoto,H.,Isobe,H.,Ito,M.,Mizuno,S. &Kawakami,Y. (1986) [Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine.]Gan To Kagaku Ryoho 13, 3541–5.PubMedGoogle Scholar
  215. Mizoguchi,M.,Naito,H.,Kurata,Y.,Shibata,M. A.,Tsuda,H.,Wild,C. P.,Montesano,R. &Fukushima,S. (1993) Influence of aging on multi-organ carcinogenesis in rats induced byN-methyl-N-nitrosourea.Jpn. J. Cancer Res. 84, 139–46.PubMedGoogle Scholar
  216. Mizukami,Y.,Nonomura,A.,Noguchi,M.,Taniya,T.,Thomas,M.,Nakamura,S. &Miyazaki,I. (1992) Effects of high and low dietary fat and indomethacin on tumour growth, hormone receptor status and growth factor expression in DMBA-induced rat breast cancer.Int. J. Tissue React. 14, 269–76.PubMedGoogle Scholar
  217. Mmitchell,I. D.,Carlton,J. B.,Chan,M. Y.,Robinson,A. &Sunderland,J. (1991) NosCapine-induced polyploidyin vitro.Mutagenesis 6, 479–86.Google Scholar
  218. Modlin,I. M.,Kumar,R.,Nangia,A.,Soroka,C. J.,Pasikhov,D. &Goldenring,J. R. (1992) Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas.Surgery 112, 1048–56; discussion 1056–8.PubMedGoogle Scholar
  219. Mori,H.,Mori,Y.,Tanaka,T.,Yoshimi,N.,Sugie,S.,Kawamori,T. &Narisawa,T. (1992) Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats.Carcinogenesis 13, 2217–20.PubMedGoogle Scholar
  220. Morimura,T. (1989) Prolongation of G1 phase in cultured glioma cells bycis-dichlorodiammineplatinum (II) (CDDP): analysis using bromodeoxyuridine (BrdU)-Hoechst technique.J. Neurooncol. 7, 71–9.PubMedCrossRefGoogle Scholar
  221. Morimura,T.,Kitz,K.,Stein,H. &Budka,H. (1991) Determination of proliferative activities in human brain tumour specimens: a comparison of three methods.J. Neurooncol. 10, 1–11.PubMedCrossRefGoogle Scholar
  222. Murovic,J. A.,Nagashima,T.,Hoshino,T.,Edwards,M. S. &Davis,R.L. (1986) Pediatric central nervous system tumours: a cell kinetic study with bromodeoxyuridine.Neurosurgery 19, 900–4.PubMedGoogle Scholar
  223. Nagashima,T. &Hoshino,T. (1985) [A cell kinetic study of human central nervous system tumours with 5-bromodeoxyuridine (BrdU).]No To Shinkei 37, 1195–202.PubMedGoogle Scholar
  224. Nagashima,T.,DeArmond,S.J.,Murovic,J. &Hoshino,T. (1985) Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumour tissues.Acta Neuropathol (Berl.) 67, 155–9.CrossRefGoogle Scholar
  225. Nagashima,T.,Hoshino,T.,Cho,K.G.,Edwards,M. S.,Hudgins,R. J. &Davis,R. L. (1988) The proliferative potential of human ependymomas measured byin situ bromodeoxyuridine labelling.Cancer 61, 2433–8.PubMedGoogle Scholar
  226. Nakagawa,Y. &Perentes,E. (1987) Determination by anti-bromodeoxyuridine monoclonal antibody of cells in S phase in the human Y79 retinoblastoma line maintained in an organ culture system: effects of butyric acid.Ophthalmic Res. 19, 205–12.PubMedGoogle Scholar
  227. Nakamura,S.,Takeda,Y.,Kanno,M.,Yoshida,T.,Ohtake,S.,Kobayashi,K.,Okabe,Y. &Matsuda,T. (1991) Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for thein vivo analysis of proliferative characteristics of human leukemia cells in bone marrows.Oncology 48, 285–9.PubMedGoogle Scholar
  228. Nakamura,T.,Masuda,K.,Matsumoto,S.,Oku,T.,Manda,T.,Mori,J. &Shimomura,K. (1989) Effect of FK973, a new antitumour antibiotic, on the cell cycle of L1210 cellsin vitro.Jpn. J. Pharmacol. 49, 317–324.PubMedGoogle Scholar
  229. Nakamura,T.,Hara,M. &Kasuga,T. (1991) Early lesion ofN-nitroso-N-ethylurea-induced hamster neurofibromatosis model.Cancer Res. 51, 434–8.PubMedGoogle Scholar
  230. Nakata,B.,Chung,Y. S.,Sawada,T.,Yokomatsu,H.,Tanaka,H.,Satake,K. &Sowa,M. (1992a) [The effect of hyperthermia against pancreatic cancer cell — various examinations including flow cytometric bromodeoxyuridine/DNA analysis.]Nippon Geka Gakkai Zasshi 93, 1324–9.PubMedGoogle Scholar
  231. Nakata,B.,Chung,Y. S.,Yokomatsu,H.,Sawada,T.,Kubo,T.,Kondo,Y.,Satake,K. &Sowa,M. (1992b) Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.Jpn. J. Cancer Res. 83, 477–82.PubMedGoogle Scholar
  232. Nakata,B.,Chung,Y. S. &Sowa,M. (1993) A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.Surg. Today 23, 717–21.PubMedCrossRefGoogle Scholar
  233. Nemoto,R.,Hattori,K.,Sasaki,A.,Miyanaga,N.,Koiso,K. &Harada,M. (1989) Estimations of the S phase fractionin situ in transitional cell carcinoma of the renal pelvis and ureter with bromodeoxyuridine labelling.Br. J. Urol. 64, 339–44.PubMedGoogle Scholar
  234. Nemoto,R.,Hattori,K.,Uchida,K.,Shimazui,T.,Koiso,K. &Harada,M. (1990a) Estimation of growth fractionin situ in human bladder cancer with bromodeoxyuridine labelling.Br. J. Urol. 65, 27–31.PubMedGoogle Scholar
  235. Nemoto,R.,Hattori,K.,Uchida,K.,Shimazui,T.,Nishijima,Y.,Koiso,K. &Harada,M. (1990b) S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labelling.Cancer 66, 509–14.PubMedGoogle Scholar
  236. Noguchi,M. &Ohta,N. (1993) Influences of high dietary fat and/or indomethacin on tumour proliferation and cell kinetics of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinomas in rats.In Vivo 7, 53–7.PubMedGoogle Scholar
  237. Noguchi,M.,Ohta,N.,Kitagawa,H.,Earashi,M.,Thomas,M.,Miyazaki,I. &Mizukami,Y. (1992) Effects of switching from a high-fat diet to a low-fat diet on tumour proliferation and cell kinetics of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.Oncology 49, 246–52.PubMedGoogle Scholar
  238. Nüsse,M.,Afzal,S. M.,Carr,B. &Kavanau,K. (1985) Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.Cytometry 6, 611–19.PubMedCrossRefGoogle Scholar
  239. Nylander,K.,Anneroth,G.,Gustafsson,H.,Roos,G.,Stenling,R. &Zackrisson,B. (1994) Cell kinetics of head and neck squamous cell carcinomas.Acta Oncologica 33, 23–28.PubMedGoogle Scholar
  240. O'donnell,A. F.,O'connell,P. R.,Royston,D.,Johnston,D. H.,Barnard,R. &Bouchier-Hayes,D. (1991) Suture technique affects perianastomotic colonic crypt cell production and tumour formation.Br. J. Surg. 78, 671–4.PubMedGoogle Scholar
  241. Ogawa,K.,Hoshiya,T.,Kato,T.,Shirai,T. &Tatematsu,M. (1992) Reversibility of carcinogen-induced rat forestomach basal cell hyperplasia is due to squamous cell differentiation.Jpn. J. Cancer Res. 83, 699–704.PubMedGoogle Scholar
  242. Ohgaki,H.,Szentirmay,Z.,Take,M. &Sugimura,T. (1989) Effects of 4-week treatment with gastric carcinogens and enhancing agents on proliferation of gastric mucosa cells in rats.Cancer Lett. 46, 117–22.PubMedCrossRefGoogle Scholar
  243. Ohi,Y. &Yoshida,H. (1992) Influence of estrogen and progesterone on the induction of mammary carcinomas by7, 12-dimethylbenz(a)anthracene in ovariectomized rats.Virchows Arch. B. Cell Pathol. 62, 365–70.Google Scholar
  244. Ohyama,C.,Nakazumi,H.,Satoh,M.,Yoshikawa,K.,Hoshi,S.,Orikasa,S.,Hayashi,T.,Mituno,S.,Murakami,F.,Kurosu,S. Et al. (1990) [S-phase cells of human bladder tumours byin vivo bromodeoxyuridine labelling.]Nippon Hinyokika Gakkai Zasshi 81, 524–31.PubMedGoogle Scholar
  245. Ohyama,S.,Yonemura,Y. &Miyazaki,I. (1989) [Flow cytometric cell cycle analysis using a monoclonal antibody to bromodeoxyuridine on gastric cancers.]Nippon Geka Gakkai Zasshi 90, 1848–54.PubMedGoogle Scholar
  246. Ohyama,S.,Yonemura,Y.,Kamata,T.,Kosaka,T.,Yamaguchi,A.,Kouichi,Y.,Miwa,K. &Miyazaki,I. (1990a) [Proliferative activity as a marker for lymph node metastases on early gastric cancers-in vitro bromodeoxyuridine labelling for clinical use.]Nippon Geka Gakkai Zasshi 91, 354–9.PubMedGoogle Scholar
  247. Ohyama,S.,Yonemura,Y. &Miyazaki,I. (1990b) Prognostic value of S-phase fraction and DNA ploidy studied within vivo administration of bromodeoxyuridine on human gastric cancers.Cancer 65, 116–21.PubMedGoogle Scholar
  248. Ohyama,S.,Yonemura,Y.,Miwa,K.,Miyazaki,I. &Sasaki,T. (1992a) Proliferation assay of human gastric remnant by bromodeoxyuridine and flow cytometry.Gastroenterology 103, 789–93.PubMedGoogle Scholar
  249. Ohyama,S.,Yonemura,Y. &Miyazaki,I. (1992b) Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.Cancer 69, 314–21.PubMedGoogle Scholar
  250. Okazaki,S.,Hoshiya,T.,Takahashi,S.,Futakuchi,M.,Saito,K. &Hirose,M. (1993) Modification of hepato- and renal carcinogenesis by catechol and its isomers in rats pretreated withN-ethyl-N-hydroxyethylnitrosamine. Teratogenesis Carcinog.Mutagen. 13, 127–37.Google Scholar
  251. Oley,J. F.,Tuck,P. D.,Ton,T.-V. K.T.,Frost,M.,Karl,F.,Anderson,M. W. &Maronpot,R. R. (1993) Inhalation exposure to a hepatocarcinogenic concentration of methyene chloride does not induce sustained replicative DNA synsthesis in hepatocytes of female B6C3F1 mice.Carcinogenesis 14, 811–7.Google Scholar
  252. Olivero,O. A.,Huitfeldt,H. &Poirier,M. C. (1990) Chromosome site-specific immunohistochemical detection of DNA adducts inN-acetoxy-2-acetylaminofluorene—exposed Chinese hamster ovary cells.Mol. Carcinog. 3, 37–43.PubMedGoogle Scholar
  253. Ooyama,S.,Yamaguchi,A.,Yonemura,Y.,Takegawa,S.,Kosaka,T.,Miwa,K. &Miyazaki,I. (1990) [Metastasis and its relation to cell kinetics in human colorectal cancers.]Nippon Geka Gakkai Zasshi 91, 677–82.PubMedGoogle Scholar
  254. Ormerod,M. G.,Imrie,P. R.,Loverock,P. &Ter Haar,G. (1992) A flow cytometric study of the effect of heat on the kinetics of cell proliferation of Chinese hamster V-79 cells.Cell Prolif. 25, 41–51.PubMedGoogle Scholar
  255. Ormerod,M. G.,Titley,J. C.,Smith,T. A.,Tombs,A. L. &Eccles,S. (1993) Proliferative behaviour of an oestrogen sensitive rat mammary tumour: evidence for a paracrine interaction between tumour and stroma.Br. J. Cancer 67, 107–11.PubMedGoogle Scholar
  256. Orton,E. C.,La,Rue SM,Ensley,B. &Stenmark,K. (1992) Bromodeoxyuridine labelling and DNA content of pulmonary arterial medial cells from hypoxia-exposed and nonexposed healthy calves.Am. J. Vet. Res. 53, 1925–30.PubMedGoogle Scholar
  257. Ozawa,S.,Ueda,M.,Ando,N.,Abe,O. &Shimizu,N. (1988) Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach.Jpn. J. Cancer Res.79, 1201–7.PubMedGoogle Scholar
  258. Paganelli,G. M.,Saccoccio,G.,Brandi,G.,Bellentani,S.,Santucci,R.,Armocida,C.,Ponz De Leon,M. &Biasco,G. (1991) Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma.Cancer Lett. 59, 221–4.PubMedCrossRefGoogle Scholar
  259. Paku,S. &Lapis,K. (1993) Morphological aspects of angiogenesis in experimental liver metastases.Am. J. Pathol. 143, 926–36.PubMedGoogle Scholar
  260. Pallavicini,M. G.,Summers,L. J.,Dolbeare,F.A. &Gray,J. W. (1985) Cytokinetic properties of asynchronous and cytosine arabinoside perturbed murine tumours measured by simultaneous bromodeoxyuridine/DNA analyses.Cytometry 6, 602–10.PubMedGoogle Scholar
  261. Parkins,C. S.,Bush,C.,Price,P. &Steel,G. G. (1991) Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.Cell Prolif. 24, 171–9.PubMedGoogle Scholar
  262. Pe,M. B.,Sano,K. &Inokuchi,T. (1993) Effects of photodynamic therapy in the normal mouse tongue.J. Oral Maxillofac. Surg. 51, 1129–34.PubMedGoogle Scholar
  263. Pellicciari,C.,Mazzini,G.,Fuhrman,Conti,A.M.,DeGradaL. &Manfredi Romanini,M.G. (1989) Effect of Hypertonic medium on human cell growth: III. Changes in cell kinetics of EUE cells.Cell Biol. Int. Rep. 13, 345–56.PubMedCrossRefGoogle Scholar
  264. Pereira,M. A. (1993) Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.Carcinogenesis 14, 299–302.PubMedGoogle Scholar
  265. Perras,J. P.,Ramos,R. &Sevin,B. U. (1993) Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.Cytometry 14, 441–8.PubMedCrossRefGoogle Scholar
  266. Piantelli,M.,Rinelli,A.,Macri,E.,Maggiano,N.,Larocca,L. M.,Scerrati,M.,Roselli,R.,Iacoangeli,M.,Scambia,G.,Capelli,A. &Ranelletti,F. O. (1993) Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas.Cancer 71, 193–8.PubMedGoogle Scholar
  267. Poot,M. &Hoehn,H. (1993) DNA topoisomerases and the DNA lesion in human genetic instability syndromes.Toxicol. Lett. 67, 297–308.PubMedCrossRefGoogle Scholar
  268. Poot,M.,Kausch,K.,Kohler,J.,Haaf,T. &Hoehn,H. (1990a) The minor-groove binding DNA-ligands netropsin, distamycin A and berenil cause polyploidisation via impairment of the G2 phase of the cell cycle.Cell Struct. Funct. 15, 151–7.PubMedGoogle Scholar
  269. Poot,M.,Koehler,J.,Rabinovitch,P. S.,Hoehn,H. &Priest,J. H. (1990b) Cell kinetic disturbances induced by treatment of human diploid fibroblasts with 5-azacytidine indicate a major role for DNA methylation in the regulation of the chromosome cycle.Hum. Genet. 84, 258–62.PubMedCrossRefGoogle Scholar
  270. Poot,M.,Schuster,A. &Hoehn,H. (1991) Cytostatic synergism between bromodeoxyuridine, bleomycin, cisplatin and chlorambucil demonstrated by a sensitive cell kinetic assay.Biochem. Pharmacol. 41, 1903–9.PubMedCrossRefGoogle Scholar
  271. Poot,M.,Epe,B. &Hoehn,H. (1992) Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.Mutat. Res. 270, 185–9.PubMedGoogle Scholar
  272. Pofert,R. J.,Joyce,A. D.,Thomas,D. J.,Walmsley,B. H. &Coptcoat,M. J. (1993) Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder — an index of recurrence?Br. J. Urol. 71, 279–83.Google Scholar
  273. Porter,A. J. &Singh,S. M. (1988) Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide.Teratogenesis Cardnog. Mutagen. 8, 191–203.Google Scholar
  274. Potten,C. S.,Kellett,M.,Roberts,S. A.,Rew,D. A. &Wilson,G. D. (1992a) Measurement ofin vivo proliferation in human colorectal mucosa using bromodeoxyuridine.Gut 33, 71–8.PubMedGoogle Scholar
  275. Potten,C. S.,Kellett,M.,Rew,D. A. &Roberts,S. A. (1992b) Proliferation in human gastrointestinal epithelium using bromodeoxyuridinein vivo: data for different sites, proximity to a tumour, and polyposis coli.Gut 33, 524–9.PubMedGoogle Scholar
  276. Preisler,H. D.,Gopal,V.,Banavali,S. D.,Finke,D. &Bokari,S. A. (1992) Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents.Cancer Res. 52, 4090–5.PubMedGoogle Scholar
  277. Qin,Y.,Schally,A. V. &Willems,G. (1992) Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160.Int. J. Cancer 52, 791–6.PubMedGoogle Scholar
  278. Radner,H. &Karcher,H. (1990) [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumours of the head and neck.]Dtsch. Z. Mund Kiefer Gesichtschir 14, 116–21.PubMedGoogle Scholar
  279. Rahman,S. A. &Tsuyama,S. (1993) Immunohistochemical study of cell proliferation and differentiation in epidermis of mice after administration of cholera toxin.Arch. Dermatol. Res. 285, 27–31.PubMedCrossRefGoogle Scholar
  280. Ramsay,J.,Suit,H. D.,Preffer,F. I. &Sedlacek,R. (1988) Changes in bromodeoxyuridine labelling index during radiation treatment of an experimental tumor.Radiat. Res. 116, 453–61.PubMedGoogle Scholar
  281. Raza,A. &Preisler,H. D. (1990) Cellular dynamics of leukaemias.Crit. Rev. Oncol. 1, 373–88.Google Scholar
  282. Raza,A. &Preisler,H. D. (1985) Double labelling of human leukemic cells using3H-cytarabine and monoclonal antibody against bromodeoxyuridine.Cancer Treat. Rep. 69, 195–8.PubMedGoogle Scholar
  283. Raza,A.,Ucar,K. &Preisler,H. D. (1985) Double labelling andin vitro versusin vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.Cytometry 6, 633–40.PubMedGoogle Scholar
  284. Raza,A.,Maheshwari,Y.,Yasin,Z.,Mandava,N.,Mayers,G. &Preisler,H. D. (1987) A new method for studying cell cycle characteristics in ANLL using double-labelling with BrdU and 3HTdr.Leuk. Res. 11, 1079–87.PubMedCrossRefGoogle Scholar
  285. Raza,A.,Gezer,S.,Mehdi,I. &Preisler,H. D. (1989a) Detection of BrdU in the regenerating bone marrow cells of a patient with AML.Leuk. Res. 13, 1055–9.PubMedCrossRefGoogle Scholar
  286. Raza,A.,Khan,S. P.,Mehdi,I.,Imren,S.,Yasin,Z. &Preisler,H. D. (1989b) Cell cycle characteristics in myeloid leukaemias.Bone Marrow Transplant 4, suppl.1, 26–9.PubMedGoogle Scholar
  287. Raza,A.,Preisler,H. D.,Day,R.,Yasin,Z.,White,M.,Lykins,J.,Kukla,C.,Barcos,M.,Bennett,J.,Browman,G. et al. (1990) Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study.Blood 76, 2191–7.PubMedGoogle Scholar
  288. Raza,A.,Bokhari,J.,Yousuf,N.,Mehdi,A.,Mazewski,C.,Khan,S.,Baker,V. &Lampkin,B. (1991a) Cell cycle kinetic studies in human cancers. Development of three DNA-specific labels in three decades.Arch. Pathol. Lab. Med. 115, 873–9.PubMedGoogle Scholar
  289. Raza,A.,Preisler,H.,Lampkin,B.,Yousuf,N.,Tucker,C.,Peters,N.,White,M.,Kukla,C.,Gartside,P.,Siegrist,C. et al. (1991b) Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemia.Br. J. Haematol. 79, 33–9.PubMedGoogle Scholar
  290. Raza,A.,Gezer,S.,Anderson,J.,Lykins,J.,Bennett,J.,Browman,G.,Goldberg,J.,Larson,R.,Vogler,R. &Preisler,H. D. (1992a) Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.Exp. Hematol. 20, 1194–201.PubMedGoogle Scholar
  291. Raza,A.,Yousuf,N.,Bohkari,S. A.,Sheikh,Y.,Akhtar,S.,Chughtai,S.,Umerani,A.,Mehdi,S. A.,Miller,M. A.,Masterson,M. et al. (1992b)In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of ILJdR/BrdU in patients with hematopoietic malignancies.Leuk. Res. 16, 299–306.PubMedCrossRefGoogle Scholar
  292. Raza,A.,Preisler,H.,Lampkin,B.,Lykins,J.,Kukla,C.,Gartside,P.,Sheikh,Y.,Yousuf,N.,White,M.,Barcos,M. et al. (1993a) Clinical and prognostic significance ofin vivo differentiation in acute myeloid leukemia.Am. J. Hematol. 42, 147–57.PubMedGoogle Scholar
  293. Raza,A.,Yousuf,N.,Bokhari,S.,Mehdi,A.,Masterson,S. M.,Lampkin,B.,Yanik,G.,Mazewski,C.,Khan,S. &Preisler,H. (1993b) Contribution ofin vivo proliferation/differentiation studies toward the development of a combined system of classification and morphologic system of classification of neoplastic diseases.Cancer, Supplement 69, 1557–66.Google Scholar
  294. Reddy,J.K. &Lalwani,N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRCCrit. Rev. Toxicol. 12, 1–58.PubMedGoogle Scholar
  295. Reddy,J. K.,Rao,M. S.,Azarnoff,D. L. &Sell,S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator [4-chloro-6-(2,3-xylidino)2-pyrimidinylthio] acetic acid (WY-14,643), in rat and mouse liver.Cancer Res. 39, 152–61.PubMedGoogle Scholar
  296. Reddy,J. K.,Azarnoff,D. L. &Hignite,C. E. (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.Nature,283, 397–9.PubMedCrossRefGoogle Scholar
  297. Remvikos,Y.,Vielh,P.,Padoy,E.,Benyahia,B.,Voillemot,N. &Magdelenat,H. (1991) Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.Br. J. Cancer 64, 501–7.PubMedGoogle Scholar
  298. Rew,D. A. (1992) Clinical applications of flow cytometry.Br. J. Hosp. Med. 48, 171–5.PubMedGoogle Scholar
  299. Rew,D. A.,Campbell,I. D.,Taylor,I. &Wilson,G. D. (1992) Proliferation indices of invasive breast carcinomas afterin vivo 5-bromo-2′-deoxyuridine labelling: a flow cytometric study of 75 tumours.Br. J. Surg. 79, 335–9.PubMedGoogle Scholar
  300. Riccardi,A.,Montecucco,C. M.,Danova,M.,Ucci,G.,Mazzini,G.,Giordano,P. &Pasquali,F. (1986) Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukaemias.Basic Appl. Histochem. 30, 181–92.PubMedGoogle Scholar
  301. Riccardi,A.,Danova,M. &Ascari,E. (1988) Bromodeoxyuridine for cell kinetic investigations in humans.Haematologica 73, 423–30.PubMedGoogle Scholar
  302. Riccardi,A.,Danova,M.,Dionigi,P.,Gaetani,P.,Cebrelli,T.,Butti,G.,Mazzini,G. &Wilson,G. (1989) Cell kinetics in leukaemia and solid tumours studied within vivo bromodeoxyuridine and flow cytometry.Br. J. Cancer 59, 898–903.PubMedGoogle Scholar
  303. Riccardi,A.,Giordano,M.,Danova,M.,Girino,M.,Brugnatelli,S.,Ucci,G. &Mazzini,G. (1991) Cell kinetics within vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia.Eur. J. Cancer 27, 882–7.PubMedGoogle Scholar
  304. Riccardi,A.,Danova,M.,Paccagnella,A.,Giordano,M.,Favaretto,A.,Panozzo,M.,Ghiotto,C.,Comis,S.,Fiorentino,M.,Chieco-Bianchi,L. &Ascari,E. (1993) Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor.Ann. Hematol. 66, 185–93.PubMedCrossRefGoogle Scholar
  305. Richardson,F. C.,Copple,D. M. &Eacho,P. I. (1992) Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposure.Carcinogenesis 13, 2453–7.PubMedGoogle Scholar
  306. Rijhsinghani,K.,Choi,H. S.,Burton,L. A.,Paronetto,F. &Tavoloni,N. (1993) Immuno-electron microscopy identification of early proliferating cells in rat liver tissue during hyperplasia induced by lead nitrate.Hepatology 17, 685–92.PubMedGoogle Scholar
  307. Risio,M. (1992) Cell proliferation in colorectal tumour progression: an immunohistochemical approach to intermediate biomarkers.J. Cell. Biochem. Suppl. 16G, 79–87.PubMedGoogle Scholar
  308. Risio,M.,Coverlizza,S.,Candelaresi,G. L.,Bertone,A.,Capfa,A. P.,Boidi-Trotti,A. &Rossini,F. P. (1990) Late cytokinetic abnormalities in irradiated rectal mucosa.Int. J. Colorectal Dis. 5, 98–102.PubMedCrossRefGoogle Scholar
  309. Risio,M.,Candelaresi,G. &Rossini,F. P. (1993) Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumour sequence.Cancer Epidemiol. Biomarkers Prev. 2, 363–7.PubMedGoogle Scholar
  310. Roemer,E.,Anton,H. J. &Kindt,R. (1993) Cell proliferation in the respiratory tract of the rat after acute inhalation of formaldehyde or acrolein.J. Appl. Toxicol. 13, 103–7.PubMedGoogle Scholar
  311. Roncucci,L.,Pedroni,M.,Scalmati,A.,Bormioli,M. L.,Sassatelli,R.,Fante,R.,Losi,L.,Di Gregorio,C.,Petocchi,B.,Ponz,De Leon, M. (1992) Cell kinetics evaluation of colorectal tumours afterin vivo administration of bromodeoxyuridine.Int. J. Cancer 52, 856–61.PubMedGoogle Scholar
  312. Roncucci,L.,Pedroni,M.,Fante,R.,DiGregorio,C.,Ponz deLeon,M. (1993) Cell kinetic evaluation of human colonic aberrant crypts.Cancer Res. 53, 3726–9.PubMedGoogle Scholar
  313. Ross,D. A.,Huaman,J. A. &Barsky,S. H. (1992) A study of the heterogeneity of the mucoepidermoid tumour and the implication for future therapies.Arch. Otolaryngol. Head Neck Surg. 118, 1172–8.PubMedGoogle Scholar
  314. Ross,R. A.,Bossart,E.,Spengler,B. A. &Biedler,J. L. (1991) Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs.Prog. Clin. Biol. Res. 366, 193–201.PubMedGoogle Scholar
  315. Ruers,T. J.,Schutte,B.,van derLinden,C. J. &Buurman,W. A. (1990) Cellular proliferation at the site of organ allografts and the influence of immunosuppressive therapy.Transplantation 50, 568–72.PubMedGoogle Scholar
  316. Russo,A.,Pacchierotti,F.,Bassani,B. &Levis,A. G. (1989) Lack of induction of somatic aneuploidy in the mouse by nitrilotriacetic acid (NTA).Mutat. Res. 226, 111–4.PubMedCrossRefGoogle Scholar
  317. Saeter,G.,Schwarze,P.E.,Nesland,J.M.,Juul,N.,Pettersen,E. &Seglen,P.O. (1988) The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas.Carcinogenesis 9, 939–45.PubMedGoogle Scholar
  318. Sahni,K.,Tribukait,B. &Einhorn,N. (1990) Development of ploidy and cell proliferation in serial samples of ascites from patients with ovarian carcinoma.Acta Oncol. 29, 193–7.PubMedGoogle Scholar
  319. Saito,K.,Uda,H.,Tanaka,S.,Kuwabara,H. &Sakamoto,H. (1992) A light and electron microscopic histochemical study on lectin binding to cells with high metastatic potential in Lewis lung carcinoma.J. Exp. Pathol. 6, 123–32.PubMedGoogle Scholar
  320. Sakamoto,S.,Sawaki,K.,Suzuki,S.,Kudo,H.,Mori,T. &Nagasawa,H. (1992) Effects of danazol on DNA synthesis in submaxillary glands of male rats.In Vivo 6, 141–3.PubMedGoogle Scholar
  321. Sakamoto,S.,Mori,T.,Sawaki,K.,Sassa,S.,Suzuki,S.,Sugiura,Y.,Kudo,H.,Kasahara,N. &Nagasawa,H. (1993) Effects of danazol on DNA synthesis in rat prostate.Prostate 22, 119–24.PubMedGoogle Scholar
  322. Sakata,K.,Aoki,Y.,Karasawa,K.,Nakagawa,K.,Hasezawa,K.,Muta,N.,Terahara,A.,Onogi,Y.,Sasaki,Y. &Akanuma,A. (1993) Analysis of the results of combined therapy for maxillary carcinoma.Cancer 71, 2715–22.PubMedGoogle Scholar
  323. San-Galli,F.,Maire,J. P. &Guerin,J. (1991) [Medulloblastoma: towards new prognostic factors.]Neurochirurgie 37, 3–11.PubMedGoogle Scholar
  324. Sarkaria,J. N.,Gibson,D. F.,Jordan,V. C.,Fowler,J. F.,Lindstrom,M. J. &Mulcahy,R. T. (1993) Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labelling and flow cytometry.Cancer Res. 53, 4413–17.PubMedGoogle Scholar
  325. Sarraf,C. E.,Ansari,T. W.,Conway,P.,Notay,M.,Hill,S. &Alison,M. R. (1993) Bromodeoxyuridine-labelled apoptosis after treatment with antimetabolites in two murine tumours and in small intestinal crypts.Br. J. Cancer 68, 678–80.PubMedGoogle Scholar
  326. Sato,K.,Kameyama,M.,Ishiwata,K.,Katakura,R. &Yoshimoto,T. (1992) Metabolic changes of glioma following chemotherapy: an experimental study using PET tracers.J. Neurooncol. 14, 81–9.PubMedCrossRefGoogle Scholar
  327. Savage,J. R. &Breckon,G. (1981) Differential effects of sulphur mustard on S-phase cells of primary fibroblast cultures from Syrian hamsters.Mutat. Res. 84, 375–87.PubMedGoogle Scholar
  328. Savage,J. R. &Prasad,R. (1988) Generalized blocking in S phase by methotrexate.Mutat. Res. 201, 195–201.PubMedGoogle Scholar
  329. Saxe,A. &Gibson,G. (1993) Effect of lithium on incorporation of bromodeoxyuridine and tritiated thymidine into human parathyroid cells.Arch. Surg. 128, 865–9.PubMedGoogle Scholar
  330. Schiffer,D.,Giordana,M. T.,Vigliani,M. C. &Cavalla,P. (1991) Relationship between glial reaction to a stab wound and tumour development after receiving transplacental ethylnitrosourea in the rat.Acta Neuropathol. (Berl.) 83, 30–8.CrossRefGoogle Scholar
  331. Scott,D.,Reuben,M.,Zampighi,G. &Sachs,G. (1990) Cell isolation and genotoxicity assessment in gastric mucosa.Dig. Dis. Sci. 35, 1217–25.PubMedCrossRefGoogle Scholar
  332. Scountzou,J.,Malisiovas,N.,Antoniadis,A. &Trakatellis,A. (1989) Inhibitory effect of deoxypyridoxine on the action of certain mitogenic factors.Immunopharmacol. Immunotoxicol. 11, 657–66.PubMedGoogle Scholar
  333. Scrivner,D. L.,Meyer,J. S.,Rujanavech,N.,Fathman,A. &Scully,T. (1991) Cell kinetics by bromodeoxyuridine labelling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies.J. Urol. 146, 1034–9.PubMedGoogle Scholar
  334. Scucchi,L.,Silecchia,G.D.I.,Stefano,D.,Spaziani,E.,Polimeno,L.,Materia,A.,Mingazzini,P. L.,Basso,N. &Marinozzi,V. (1992) Interphasic nucleolar organizer regions expression and cell kinetics evaluation during gastric carcinogenesis induced by nitrosoguanidine in the rat.Virchows Arch. B. Cell Pathol. 62, 303–9.Google Scholar
  335. Shibuya,M.,Hoshino,T.,Ito,S.,Wacker,M. R.,Prados,M. D.,Davis,R. L. &Wilson,C. B. (1992a) Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labelling.Neurosurgery 30, 494–7; discussion 49.PubMedGoogle Scholar
  336. Shibuya,M.,Saito,F.,Miwa,T.,Davis,R. L.,Wilson,C. B. &Hoshino,T. (1992b) Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling, and nucleolar organizer region counts.Acta Neuropathol (Berl.) 84, 178–83.CrossRefGoogle Scholar
  337. Shibuya,M.,Ito,S.,Davis,R. L.,Wilson,C. B. &Hoshino,T. (1993a) A new method for analyzing the cell kinetics of human brain tumours by double labelling with bromodeoxyuridinein situ and with iododeoxyuridinein vitro.Cancer 71, 3109–13.PubMedGoogle Scholar
  338. Shibuya,M.,Ito,S.,Miwa,T.,Davis,R. L.,Wilson,C. B. &Hoshino,T. (1993b) Proliferative potential of brain tumours. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling, and nuclear organizer region counts.Cancer 71, 199–206.PubMedGoogle Scholar
  339. Shimabukuro,T. (1988) [Application of simultaneous flow cytometric bromodeoxyuridine (BrdU)/DNA analysis. 2. Basic study to apply as a chemosensitivity test.]Hinyokika Kiyo 34, 1349–55.PubMedGoogle Scholar
  340. Shimabukuro,T.,Yamamoto,M.,Mitsui,H.,Yamamoto,N.,Sakatoku,J.,Harada,H. &Sacho,T. (1989a) [Cell kinetic study of urogenital tumours utilizingin vitro BrdU-labelling method and anti-BrdU monoclonal antibody.]Hinyokika Kiyo 35, 1285–90.PubMedGoogle Scholar
  341. Shimabukuro,T.,Yamamoto,M.,Mitsui,H.,Yamamoto,N.,Sakatoku,J. &Shinohara,Y. (1989b) [Study of flow cytometric BrdU/DNA assay.]Nippon Gan Chiryo Gakkai Shi 24, 1249–55.PubMedGoogle Scholar
  342. Shimizu,T.,Sakakura,Y.,Hattori,T.,Yamaguchi,N.,Kubo,M. &Sakakura,K. (1990) Superselective intraarterial chemotherapy in combination with irradiation: preliminary report.Am. J. Otolaryngol. 11, 131–6.PubMedGoogle Scholar
  343. Shimosato, Y., Asamura, H. &Yoshida, K. (1989a) [The degree of malignancy in lung adenocarcinoma and related factors — nuclear DNA content and bromodeoxyuridine labelling index.]Gan No Rinsho Spec., 183–8.Google Scholar
  344. Shimosato,Y.,Asamura,H.,Yoshida,K.,Noguchi,M.,Nakajima,T. &Mukai,K. (1989b) Factors possibly affecting the degree of malignancy in adenocarcinoma of the lung. DNA content and bromodeoxyuridine (BrdU) labelling index.Chest 96, 37S-38S.PubMedGoogle Scholar
  345. Shinoda,K.,Okamiya,H.,Imazawa,T.,Furukawa,F.,Toyoda,K.,Sato,H. &Taka-Hashi,M. (1989) [Application of BrdU-immunohistochemistry and lanthanum-tracer methods to the pathological evaluation of 1,3-dinitrobenzene testicular toxicity.]Eisei Shikenjo Hokoku 1, 63–7.Google Scholar
  346. Shirai,T.,Nakamura,A.,Wada,S. &Ito,N. (1989) Pancreatic acinar cell tumours in rats induced by 3,2′-dimethyl-4-aminobiphenyl.Carcinogenesis 10, 127–30.Google Scholar
  347. Sieweke,M. H.,Stoker,A. W. &Bissell,M. J. (1989) Evaluation of the cocarcinogenic effect of wounding in Rous sarcoma virus tumourigenesis.Cancer Res. 49, 6419–24.PubMedGoogle Scholar
  348. Smit,N. P.,Peters,K.,Menko,W.,Westerhof,W.,Pavel,S. &Riley,P. A. (1992) Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells.Melanoma Res. 2, 295–304.PubMedGoogle Scholar
  349. Smith,P. F.,O'Brien,K. A. &Keenan,K. P. (1991) Evaluation of bromodeoxyuridine labelling in hepatomegaly produced by peroxisomal proliferation proliferation or P-450 induction on rodents.Prog. Clin. Biol. Res. 369, 285–9.PubMedGoogle Scholar
  350. Smuckler,E. A. &Gans,J. H. (1980) Thein vivo incorporation of triated thymidine into liver cell nuclear DNA in mice treated chronically with carbon tetrachloride or with diethylnitrosamine.Exp. Mol. Pathol. 33, 65–73.PubMedCrossRefGoogle Scholar
  351. Sobhani,I.,Lehy,T.,Laurent-Puig,P.,Cadiot,G.,Ruszniewski,P. &Mignon,M. (1993) Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa.Gastroenterology 105, 22–30.PubMedGoogle Scholar
  352. Sorbye,H.,Kvinnsland,S. &Svanes,K. (1993) Penetration ofN-methyl-N′-nitro-N-nitrosoguanidine to proliferative cells in gastric mucosa of rats is different in pylorus and fundus and depends on exposure time and solvent.Carcinogenesis 14, 887–92.PubMedGoogle Scholar
  353. Sowa,M.,Nishimura,M.,Yoshino,H.,Kubo,T.,Kato,Y.,Chung,Y. S. &Umeyama,K. (1990) Experimental gastric cancer induced byN-methylN′-nitro-N-nitrosoguanidine in rats.Osaka City Med. J. 36, 37–51.PubMedGoogle Scholar
  354. Stephenson,C. F.,Desai,Z. R. &Bridges,J. M. (1991) The proliferative activity of B-chronic lymphocytic leukaemia lymphocytes prior to and after stimulation with TPA and PHA.Leuk. Res. 15, 1005–12.PubMedCrossRefGoogle Scholar
  355. Sugi,Y.,Sasse,J. &Lough,J. (1993) Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2).Dev. Biol. 157, 28–37.PubMedCrossRefGoogle Scholar
  356. Sugiyama,K.,Yonemura,Y.,Takamura,H.,Miwa,K. &Miyazaki,I. (1993) [Preoperative prediction of gastric cancer development byin vitro labelling index of bromodeoxyuridine.]Gan To Kagaku Ryoho 20, 796–8.PubMedGoogle Scholar
  357. Suzuki,H. (1988) The prognostic value of flow cytometric DNA analysis in colorectal cancer patients.Jpn. J. Surg. 18, 483–6.PubMedGoogle Scholar
  358. Svensson,M. &Aldskogius,H. (1993) Infusion of cytosine-arabinoside into the cerebrospinal fluid of the rat brain inhibits the microglial cell proliferation after hypoglossal nerve injury.Glia 7, 286–98.PubMedCrossRefGoogle Scholar
  359. Svoboda,D. J. &Azarnoff,D. L. (1979) Tumours in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipemic drug.Cancer Res. 39, 3419–28.PubMedGoogle Scholar
  360. Tabibzadeh,S. S.,Satyaswaroop,P. G. &Rao,P. N. (1988) Antiproliferative effect of interferon-gamma in human endometrial epithelial cells in vitro: potential local growth modulatory role in endometrium.J. Clin. Endocrinol. Metab. 67, 131–8.PubMedGoogle Scholar
  361. Tachibana,M.,Deguchi,N.,Jitsukawa,S.,Baba,S.,Hata,M. &Tazaki,H. (1991) Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.J. Urol. 145, 963–7.PubMedGoogle Scholar
  362. Tachibana,M.,Deguchi,N.,Baba,S.,Jitsukawa,S.,Hata,M. &Tazaki,H. (1993) Prognostic significance of bromodeoxuridine high labelled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder?J. Urol. 149, 739–43.PubMedGoogle Scholar
  363. Tada,T.,Kodama,T.,Watanabe,S.,Sato,Y. &Shimosato,Y. (1986) Immunohistochemical cell kinetic study of human lung cancer by using monoclonal antibody to bromodeoxyuridine.Jpn. J. Clin. Oncol. 16, 129–35.PubMedGoogle Scholar
  364. Takahashi,M.,Hasegawa,T.,Furukawa,F.,Okamiya,H.,Shinoda,K.,Imaida,K.,Toyoda,K. &Hayashi,Y. (1991) Enhanced lipid peroxidation in rat gastric mucosa caused by NaCl.Carcinogenesis 12, 2201–4.PubMedGoogle Scholar
  365. Takase,K.,Sawai,M.,Yamamoto,K.,Yata,J.,Takasaki,Y.,Teraoka,H. &Tsukada,K. (1992) Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Rafi cells.Cell Growth Differ. 3, 515–21.PubMedGoogle Scholar
  366. Takegawa,S. (1992) [Correlation of DNA index and BrdU labelling index with clinicopathological factors in colorectal carcinoma.]Nippon Geka Gakkai Zasshi 93, 607–15.PubMedGoogle Scholar
  367. Tamura,M.,Tsukahara,T.,Kunimine,H.,Zama,A.,Tamaki,Y. &Niibe,H. (1989) [Histopathologic changes and tumour cell kinetics after hyperthermia and/or radiation therapy in a rat glioma model: bromodeoxyuridine (BUdR) labelling index.]No Shinkei Geka 17, 555–9.PubMedGoogle Scholar
  368. Tamura,T.,Sugiyama,M.,Uekawa,M.,Nakai,Y.,Onoyama,Y. &Nakajima,T. (1991) Synergistic effects of irradiation and hyperthermia on established cell lines derived from maxillary carcinoma. Report II.Acta Otolaryngol. Suppl. (Stockh) 486, 234–44.Google Scholar
  369. Tanaka,K.,Smith,P. F.,Stromberg,P. C.,Eydelloth,R. S.,Herold,E. G.,Grossman,S.J.,Frank,J. D.,Hertzog,P. R.,Soper,K. A. &Keenan,K. P. (1992) Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumourigenic doses of clofibrate.Toxicol. Appl. Pharmacol. 116, 71–7.PubMedCrossRefGoogle Scholar
  370. Tanaka,N.,Tatemoto,A.,Urabe,T.,Ono,M.,Hizuta,A.,Naomoto,Y.,Gotoh,K.,Moreira,L. F. &Orita,K. (1993a) Inhibition of liver regeneration in mice following extended hepatectomy by transfusion of lymphokine activated killer cells.Acta Med. Okayama 47, 21–8.PubMedGoogle Scholar
  371. Tanaka,N.,Yamamoto,H.,Tatemoto,A.,Urabe,T. &Orita,K. (1993b) Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506.Int. J. Immunopharmacol. 15, 211–8.PubMedCrossRefGoogle Scholar
  372. Tanaka,T.,Takeuchi,T.,Nishikawa,A.,Takami,T. &Mori,H. (1989) Nucleolar organizer regions in hepatocarcinogenesis induced byN-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry.Jpn. J. Cancer Res. 80, 1047–51.PubMedGoogle Scholar
  373. Tanaka,T.,Kojima,T.,Suzui,M. &Mori,H. (1993) Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumour development and biomarkers expression of colon tumourigenesis.Cancer Res. 53, 3908–12.PubMedGoogle Scholar
  374. Taniguchi,H.,Shioaki,Y.,Daidoh,T.,Itoh,A.,Tsukuda,N.,Yamaguchi,T.,Sawai,K. &Takahashi,T. (1989) [Clinical study of the drug delivery in metastatic liver cancer using bromodeoxyuridine.]Gan To Kagaku Ryoho 16, 3015–18.PubMedGoogle Scholar
  375. Taniguchi,H.,Daidoh,T.,Shioaki,Y. &Takahashi,T. (1993) Blood supply and drug delivery to primary and secondary human liver cancers studied within vivo bromodeoxyuridine labelling.Cancer 71, 50–5.PubMedGoogle Scholar
  376. Tarao,K.,Shimizu,A.,Harada,M.,Ohkawa,S.,Okamoto,N.,Kuni,Y.,Yoshihiko,I.,Tamai,S.,Iimori,K.,Sugimasa,I.,Takemiya,S.,Okamoto,T.,Inoue,T. &Kanisawa,M. (1991a)In vitro uptake of bormodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior.Cancer 68, 1789–94.PubMedGoogle Scholar
  377. Tarao,K.,Shimizu,A.,Harada,M.,Ono,T.,Kuni,Y.,Ohkawa,S.,Ito,Y.,Tamai,S.,Imori,K.,Sugimasa,Y. et al. (1991b) Evidence of sex difference in DNA synthesis in hepatocellular carcinoma.Jpn. J. Cancer Res. 82, 922–6.PubMedGoogle Scholar
  378. Tarao,K.,Ohkawa,S.,Shimizu,A.,Harada,M.,Nakamura,Y.,Ito,Y.,Tamai,S.,Hoshino,H.,Okamoto,N.,Imori,K.,et al. (1993a) The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men.Cancer 72, 369–74.PubMedGoogle Scholar
  379. Tarao,K.,Ohkawa,S.,Shimizu,A.,Harada,M.,Nakamura,Y.,Okamoto,N.,Ito,Y.,Tamai,S.,Iimori,K.,Sugimasa,Y. et al. (1993b) DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.Cancer 71, 3859–63.PubMedGoogle Scholar
  380. Tashima,T.,Fukui,M.,Nishio,S.,Fujii,K. &Iwaki,T. (1990) Radiation-induced meningiomas and their proliferative activity. Cytokinetic study using bromodeoxyuridine.Acta Neurochir. (Wien) 102, 69–72.CrossRefGoogle Scholar
  381. Tatematsu,M.,Fukushima,S.,Aoki,T.,Mera,Y.,Inoue,T. &Ito,N. (1987) Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.Jpn. J. Cancer Res. 78, 879–82.PubMedGoogle Scholar
  382. Tatsuta,M.,Iishi,H.,Baba,M.,Yamamura,H. &Taniguchi,H. (1988) Enhancement by prolonged administration of caerulein of experimental carcinogenesis induced byN-methyl-N′-nitro-N-nitrosoguanidine in rat stomach.Cancer Res. 48, 6332–5.PubMedGoogle Scholar
  383. TeBoekhorst,P. A.,Lowenberg,B. &Sonneveld,P. (1993a) Enhanced chemosensitivity in acute myeoloid leukaemia by heamtopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.Leukaemia 7, 1637–44.Google Scholar
  384. TeBoekhorst,P. A.,Lowenberg,B.,Vlastuin,M. &Sonneveld,P. (1993b) Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukaemia by G-CSF, IL-3 or GM-CSF stimulation.Leukaemia 7, 1191–8.Google Scholar
  385. Tenjin,T. (1988) [The effects of adriamycin on the cell cycle by bromodeoxyuridine-labelling method.]Nippon Gan Chiryo Gakkai Shi 23, 1623–32.PubMedGoogle Scholar
  386. Tenjin,T.,Kimura,T.,Takeda,H.,Sakagami,S.,Takahashi,N.,Shoji,T. &Asano,G. (1989) [Effect of adriamycin on cell cycle by bromodeoxyuridine-labelling method.]Gan To Kagaku Ryoho 16, 3781–6.PubMedGoogle Scholar
  387. Tennenbaum,T.,Weiner,A. K.,Belanger,A. J.,Glick,A. G.,Hennings,H. &Yuspa,S. H. (1993) The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.Cancer Res.53, 4803–10.PubMedGoogle Scholar
  388. TenVelde,G. P.,Schutte,B.,Reijnders,M. M.,Bosman,F. T. &Blijham,G. H. (1989) Cytokinetic analysis of lung cancer by bromodeoxyuridine labelling of cytology specimens.Cytometry 10, 807–10.PubMedGoogle Scholar
  389. Thames,H. D.,Peters,L. J.,Withers,H. R. &FletcherG. H. (1983) Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day.Int. J. Rad. Oncol. Biol Phys. 9, 127–38.Google Scholar
  390. Thornton,J. G.,Wells,M. &Hume,W. J. (1988) Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine.J. Pathol. 154, 321–8.PubMedCrossRefGoogle Scholar
  391. Thornton,J. G.,Wells,M. &Hume,W. J. (1989) Measurement of the S-phase duration in normal and abnormal human endometrium byin vitro double labelling with bromodeoxyuridine and tritiated thymidine.J. Pathol. 157, 109–15.PubMedCrossRefGoogle Scholar
  392. Tinnemans,M. M.,Schutte,B.,Lenders,M. H.,TenVelde,G. P.,Ramaekers,F. C., &Blijham,G. H. (1993) Cytokinetic analysis of lung cancer byin vivo bromodeoxyuridine labelling.Br. J. Cancer 67, 1217–22.PubMedGoogle Scholar
  393. Tobey,R. A.,Oishi,N. &Crissman,H. A. (1989) Synchronized human diploid fibroblasts: progression capabilities of a subpopulation that fails to keep pace with the predominant, rapidly dividing cohort of cells.J. Cell. Physiol. 139, 432–40.PubMedCrossRefGoogle Scholar
  394. Tokita,K.,Tsuchihashi,Y.,Mitsufufi,S.,Isetani,K.,Hosokawa,Y.,Tani,T.,Maruyama,K.,Yorioka,S.,Suzuki,G.,Takanshi,T. et al. (1990) [Cell proliferation in a triple gastric cancer — a study using the isolated organ perfusion system.]Gan No Rinsho 36, 801–9.PubMedGoogle Scholar
  395. Tse,C. S. &Williams,D. M. (1992) Inhibition of human endothelial cell proliferationin vitro in repsonse ton-butyrate and propionate.J. Periodontal. Res. 27, 506–10.PubMedGoogle Scholar
  396. Tsubura,A.,Takahashi,H. &Moril,S. (1992) DMBA-induced intestinal tumours in the Japanese house musk shrew,Suncus murinus (Insectivora).In Vivo 6, 255–60.PubMedGoogle Scholar
  397. Tsuda,H.,Ozaki,K.,Uwagawa,S.,Yamaguchi,S.,Hakoi,K.,Aoki,T.,Kato,T.,Sato,K. &Ito,N. (1992) Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.Jpn. J. Cancer Res. 83, 1154–65.PubMedGoogle Scholar
  398. Tsuji,Y.,Hashimoto,K.,Takeda,J. &Kakegawa,T. (1992) [Cell kinetic effect of carcinostatic agents using BrdU and its monoclonal antibody.]Nippon Rinsho 50, 2381–5.PubMedGoogle Scholar
  399. Tsujihashi,H.,Matsuda,H.,Uejima,S.,Akiyama,T. &Kurita,T. (1989) Cell proliferation of human bladder tumours.J. Urol. 142, 1113–16.PubMedGoogle Scholar
  400. Tsujihashi,H.,Matsuda,H.,Uejima,S.,Akiyama,T. &Kurita,T. (1990) The kinetics of cellular proliferation in rat urinary bladder treated withN-butyl-N-(4-hydroxybutyl)nitrosamine.J. Urol. 144, 1493–96.PubMedGoogle Scholar
  401. Tsurusawa,M.,Niwa,M.,Katano,N. &FujiMoto,T. (1988) Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukaemia ceUs.Cancer Res. 48, 4288–93.PubMedGoogle Scholar
  402. Tsurusawa,M.,Niwa,M.,Katano,N. &Fujimoto,T. (1990) Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukaemia cells.Jpn. J. Cancer Res. 81, 85–90.PubMedGoogle Scholar
  403. Tsushima,H. (1993) [Clinical study on the cell kinetics of gastric cancer using bromodeoxyuridine labelling index — its relations with DNA ploidy pattern and epidermal growth factor.]Nippon Geka Gakkai Zasshi 94, 41–9.PubMedGoogle Scholar
  404. Ubezio,P.,Filippeschi,S. &Spinelli,L. (1991) Method for kinetic analysis of drug-induced cell cycle perturbations.Cytometry 12, 119–26.PubMedCrossRefGoogle Scholar
  405. Umemura,T.,Tokumo,K. &Williams,G. M. (1992) Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogenp-dichlorobenzene.Arch. Toxicol. 66, 503–7.PubMedCrossRefGoogle Scholar
  406. Umemura,T.,Tokumo,K.,Sirma,H.,Gebhardt,T.,Poirier,M. C. &Williams,G. M. (1993) Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver.Cancer Lett. 73, 1–10.PubMedCrossRefGoogle Scholar
  407. VanBenthem,J.,Vermeulen,E.,Winterwerp,H. H.,Wild,C. P.,Scherer,E. &DenEngelse,L. (1992) Accumulation of O6- and 7-methylguanine in DNA ofN-nitroso-N-methylbenzylamine-treated rats is restricted to non-target organs forN-nitroso-N-methylbenzylamine-induced carcinogenesis.Carcinogenesis. 13, 2101–5.PubMedGoogle Scholar
  408. VanDierendonck,J. H.,Keijzer,R.,Cornelisse,C. J. &van de Velde,C. J. (1991) Surgically induced cytokinetic responses in experimental rat mammary tumour models.Cancer 68, 759–67.PubMedGoogle Scholar
  409. VanOostrum,I. E.,Rozemuller,E.,Knol,R. F.,Erkens-Schulze,S. &Rutgers,D. H. (1990) Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.Cell Tissue Kinet. 23, 523–44.PubMedGoogle Scholar
  410. VanWeerden,W. M.,VanKreuningen,A.,Elissen,N. M.,DeJong,F. H.,VanSteenbrugge,G. J. &Schroder,F. H. (1992) Effects of adrenal androgens on the transplantable human prostate tumour PC-82.Endocrinology 131, 2909–13.PubMedGoogle Scholar
  411. Verhagen,H.,Schutte,B.,Reynders,M. M.,Blijham,G. H.,TenHoorF. &Kleinjans,J. C. (1988) Effect of short-term dietary administration of burylated hydroxyanisole on cell kinetic parameters in rate gastrointestinal tract, assessed by immunocytochemistry and flow cytometry.Carcinogenesis 9, 1107–9.PubMedGoogle Scholar
  412. Vinogradov,A. E.,Ezhevsky,S. A.,Rosanov,J. M.,Kazhdan,I. A. &Zweibach,A. S. (1991) Loosening of cell cycle controls of human lymphocytes under the action of tumour promoter TPA.Cell Prolif. 24, 493–505.PubMedGoogle Scholar
  413. Wada,Y.,Kawamoto,K.,Oka,S.,Yamashita,T.,Jumazawa,T. &Matsumura,H. (1989) Clinical evaluation for the mechanism of cisplatin with bromodeoxyuridine by flow cytometry and clinico-histological study.Life Sci. 44, 259–64.PubMedCrossRefGoogle Scholar
  414. Waldman,F. M.,Dolbeare,F. &Gray,J. W. (1985) Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.Cytometry 6, 657–62.PubMedCrossRefGoogle Scholar
  415. Waldman,F. M.,Dolbeare,F. &Gray,J. (1988) Clinical applications of the bromodeoxyuridine/DNA assay.Cytometry Suppl. 3, 65–72.PubMedGoogle Scholar
  416. Waldman,F. M.,Chew,K.,Ljung,B. M.,Goodson,W.,Hom,J.,Duarte,L. A.,Smith,H. S. &Mayall,B. (1991) A comparison between bromodeoxyuridine and3H thymidine labelling in human breast tumours.Mod. Pathol. 4, 718–22.PubMedGoogle Scholar
  417. Waldman,F. M.,Carrol,P. R.,Cohen,M. B.,Kerschmann,R.,Chew,K. &Mayall,B. H. (1993) 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.Mod. Pathol. 6, 20–4.PubMedGoogle Scholar
  418. Wang,J. Z.,Tian,X.,Tsumura,H.,Shimura,K. &Ito,H. (1993) Antitumour activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms.Anticancer Drug Des. 8, 193–202.PubMedGoogle Scholar
  419. Ward,J. M.,Weghorst,C. M.,Diwan,B. A.,Konishi,N.,Lubet,R. A.,Henneman,J. R. &Devor,D. E. (1991) Evaluation of cell proliferation in the kidneys of rodents with bromodeoxyuridine immunohistochemistry of tritiated thymidine autorodiography after exposure to renal toxins, tumour promoters, and carcinogens.Prog. Clin. Biol. Res. 369, 369–88.PubMedGoogle Scholar
  420. Watson,P. A.,Hanauske-Abel,H. H.,Flint,A. &Lalande,M. (1991) Mimosine reversibly arrests cell cycle progression at the G1-S phase border.Cytometry 12, 242–6.PubMedCrossRefGoogle Scholar
  421. Weidner,N.,Moore,D. H.,Ljung,B. M.,Waldman,F. M.,Goodson,W. H.,Mayall,B.,Chew,K. &Smith,H. S. (1993) Correlation of bromodeoxyuridine (BRDU) labelling of breast carcinoma cells with mitotic figure content and tumour grade.Am. J. Surg. Pathol. 17, 987–94.PubMedGoogle Scholar
  422. Welberg,J. W.,DeVries,E. G.,Hardonk,M. J.,Mulder,N. H.,Harms,G.,Grond,J.,Zwart,N.,Koudstaal,J.,DeLey,L. &Kleibeuker,J. H. (1990) Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method.J. Clin. Pathol. 43, 453–6.PubMedGoogle Scholar
  423. Weller,E. M.,Poot,M. &Hoehn,H. (1993) Induction of replicative senescence by 5-azacytidine: fundamental cell kinetic differences between human diploid fibroblasts and NIH-3T3 cells.Cell Prolif. 26, 45–54.PubMedGoogle Scholar
  424. Wenz,F.,Lohr,F.,Peschke,P.,Wolber,G.,Hover,K. H. &Hahn,E. W. (1993) [The relative biological effectiveness (RBE) of fast neutrons on the Dunning rat prostate carcinoma R3327-HL.]Strahlenther Onkol. 169, 412–17.PubMedGoogle Scholar
  425. Williams,S. D. &Einhorn,L. H. (1980) Cisplatin chemotherapy of testicular cancer. InCisplatin: Current Status and New Developments (edited byPrestayko,A. W.,Crook,S. T. &Carter,S. K.), pp. 323–8. New York: Academic Press.Google Scholar
  426. Williams,K.,Halliday,I.,Hamilton,P.,Ruddell,J.,Varma,M.,Maxwell,P.,Crockard,A. &Rowlands,B. (1993)In vitro BrdUrd incorporation of colorectal tumour tissue.Cell Prolif. 26, 115–24.Google Scholar
  427. Wilson,G. D. (1991) Assessment of human tumour proliferation using bromodeoxyuridine — current status.Acta Oncol. 30, 903–10.PubMedGoogle Scholar
  428. Wilson,G. D. (1992) The future of flow cytometry.BJR Suppl. 24, 158–62.PubMedGoogle Scholar
  429. Wilson, G. D. (1993) Limitations of the bromodeoxyuridine technique for measurement of tumour proliferation. InMedical Radiology, Current Topics in Clinical Radiobiology of Tumours (edited byBeckbordnholdt, H. P.), pp. 22–47. Springer-Verlag.Google Scholar
  430. Wilson,G. G. &Mcnally,N. J. (1991) Measurement of cell proliferation using bromodeoxyuridine. InAssessment of cell Proliferation in Clinical Practice (edited byHall,P. A.,Levison,D. A. &Wright,N. A.). London: Springer-Verlag.Google Scholar
  431. Wilson,G. D.,Martindale,C. A.,Soranson,J. A.,Carl,U. M. &Mcnally,N. J. (1992) Proliferative changes in two murine tumours in response to single or fractionated doses of X-rays.Cell Prolif. 25, 415–30.PubMedGoogle Scholar
  432. Wilson,M. S.,West,C. M. L.,Wilson,G. D.,Roberts,S. A.,James,R.D. &Schofield,P. F. (1993) The reliability and reproducibility of measurements of potential doubling times (Tpot) on human colorectal cancers.Br. J. Cancer 67, 754–9.PubMedGoogle Scholar
  433. Wong,R. S.,Borrelli,M. J.,Thompson,L. L. &Dewey,W. C. (1989) Mechanism of killing Chinese hamster ovary cells heated in G1: effects on DNA synthesis and blocking in G2.Radiat. Res. 118, 295–310.PubMedGoogle Scholar
  434. Xie,Y. J. (1991) [Immunohistochemical observation on the proliferative activity of rat liver in early hepatocarcinogenesis.]Chung-hua Ping Li Hsueh Tsa Chih 20, 95–7.PubMedGoogle Scholar
  435. Yabushita,H.,Sawaguchi,K.,Ueno,N.,Hieda,S.,Noguchi,M. &Ishihara,M. (1989) [Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer.]Gan To Kagaku Ryoho 16, 235–41.PubMedGoogle Scholar
  436. Yagura,T.,Kozu,T. &Seno,T. (1982) Arrest of chain growth replicon-sized intermediates by aphidicolin during rat fibroblast cell chromosome replication.Europ. J. Biochem. 123, 15–21.PubMedCrossRefGoogle Scholar
  437. Yamaghishi,T.,Nakaike,S.,Nanaumi,K.,Otomo,S. &Tsukagoshi,S. (1993) The effect of NC-190, a novel antitumour compound, on the cell-cycle progression of HeLa S3 cells.Cancer Chemother. Pharmacol. 32, 249–54.Google Scholar
  438. Yamaguchi,K.,Imanishi,K.,Maruno,K.,Miyake,Y.,Shimosato,Y. &Abe,K. (1989) Lung cancer and autocrine growth factors.Chest 96, 9S-31S.Google Scholar
  439. Yamamoto,Y.,Makimoto,K. &Takahashi,H. (1990) Cell kinetic study on experimental tongue carcinoma in rats.Acta Otolaryngol. (Stockh) 110, 314–20.Google Scholar
  440. Yamazaki,K.,Saito,S.,Motoo,N.,Taguchi,K. &Nishimura,N. (1990) [Cell kinetics of experimental pancreatic cancers in Syrian golden hamsters using intraperitoneal continuous bromodeoxyuridine infusion.]Nippon Shokakibyo Gakkai Zasshi 87, 1084.PubMedGoogle Scholar
  441. Yamazaki,K.,Saito,S.,Nishimura,N.,Taguchi,K.,MotoO. N.,Kubota,Y.,Tanaka,M. &Watanabe,A. (1991) Cell-kinetic analysis of pancreatic cancers in Syrian golden hamsters.Int. J. Pancreatol. 10, 121–32.PubMedGoogle Scholar
  442. Yanik,G.,Yousuf,N.,Miller,M. A.,Swerdlow,S. H.,Lampkin,B. &Raza,A. (1992)In vivo determination of cell cycle kinetics of non-Hodgkin's lymphomas using iododeoxyuridine and bromodeoxyuridine.J Histochem. Cytochem. 40, 723–8.PubMedGoogle Scholar
  443. Yin,M.,Gopal,V.,Banavali,S.,Gartside,P. &Preisler,H. (1992) Effects of an IL-1 receptor antagonist on acute myeloid leukaemia cells.Leukaemia 6, 898–901.Google Scholar
  444. Yonemura,Y.,Sugiyama,K.,Fujimura,T.,DeAretxabala,X.,Kamata,T.,Kosaka,T.,Yamaguchi,A.,Miwa,K. &Miyazaki,I. (1988a) Correlation of DNA ploidy and proliferative activity in human gastric cancer.Cancer 62, 1497–503.PubMedGoogle Scholar
  445. Yonemura,Y.,Sugiyama,K.,Kamata,T.,Fujimura,T.,Yamaguchi,A.,Miwa,K. &Miyazaki,I. (1988b) [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity.]Nippon Geka Gakkai Zasshi 89, 1175–80.PubMedGoogle Scholar
  446. Yonemura,Y.,Sugiyama,K.,Kamata,T.,Fushida,S.,Yamaguchi,A.,Miwa,K. &Miyazaki,I. (1988c) [Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma.]Nippon Geka Gakkai Zasshi 89, 1611–15.PubMedGoogle Scholar
  447. Yonemura,Y.,Sugiyama,K.,Fujimura,T.,Kamata,T.,Fushida,S.,Yamaguchi,A.,DeAretxebala,X.,Miwa,K. &Miyazaki,I. (1989) Epidermal growth factor receptor status and S-phase fractions in gastric carcinoma.Oncology 46, 158–61.PubMedGoogle Scholar
  448. Yonemura,Y.,Kamata,T.,Ohoyama,S.,Matumoto,H.,Kimura,H.,Kosaka,T.,Yamaguchi,A.,Miwa,K. &Miyazaki,I. (1991a) Relation of proliferative activity to survival in patients with advanced gastric cancer.Anal. Cell Pathol. 3, 103–10.PubMedGoogle Scholar
  449. Yonemura,Y.,Sugiyama,K.,Fushida,S.,Kamata,T.,Ohoyama,S.,Kimura,H.,Yamaguchi,A. &Miyazaki,I. (1991b) Tissue status of epidermal growth factor and its receptor as an indicator of poor prognosis in patients with gastric cancer.Anal. Cell Pathol. 3, 343–50.PubMedGoogle Scholar
  450. Yonemura,Y.,Ohoyama,S.,Kimura,H.,Matumoto,H.,Ninomiya,I.,Kosaka,T.,Yamaguchi,A.,Miwa,K. &Miyazaki,I. (1992) Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer.Surg. Today 22, 416–20.PubMedGoogle Scholar
  451. Yonemura,Y.,Kimura,H.,Fushida,S.,Tugawa,K.,Nakai,Y.,Kaji,M.,Fonseca,L.,Yamaguchi,A. &Miyazaki,I. (1993) Analysis of proliferative activity using ami-proliferating cell nuclear antigen antiboyd in gastric cancer tissue specimens obtained by endoscopic biopsy.Cancer 71, 2448–53.PubMedGoogle Scholar
  452. Yong,V. W.,Tejada, Berges,T.,Goodyer,C. G.,Antel,J. P. &Yond,F. P. (1992) Differential proliferative response of human and mouse astrocytes to gamma-interferon.Glia 6, 269–80.PubMedCrossRefGoogle Scholar
  453. Yoshida,A.,Fukazawa,M.,Ushio,H.,Aiyoshi,Y.,Soeda,S. &Ito,K. (1989) Study of cell kinetics in anaplastic thyroid carcinoma transplanted to nude mice.J. Surg. Oncol. 41, 1–4.PubMedGoogle Scholar
  454. Yoshida,K.,Morinaga,S.,Shomosato,Y. &Hayata,Y. (1989) A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labelling.Cancer 64. 2284–91.PubMedGoogle Scholar
  455. Yoshida,Y.,Kumanishi,T.,Abe,S.,Nishiyama,A.,Yamada,M. &Hinokuma,K. (1989) Glomeruloid blood vessels in ethylnitrosourea-induced rat gliomas. Histological and immunohistochemical studies.Acta Neuropathol. (Berl.)79, 240–7.CrossRefGoogle Scholar
  456. Yoshii,Y.,Maki,Y.,Tsuboi,K.,Tomono,Y.,Nakagawa,K. &Hoshino,T. (1986) Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumours.J. Neurosurg. 65, 659–663.PubMedGoogle Scholar
  457. Yoshii,Y.,Maki,Y.,Matsuki,T.,Komatsu,Y.,Tsurushima,H.,Yamada,Y.,Higuchi,O.,Sugimoto,K.,Takeuchi,S. &Hoshino,T. (1987) [Growth fraction of human central nervous system tumours measured by using bromodeoxyuridine.]Neurol. Med. Chir. (Tokyo) 27, 482–90.Google Scholar
  458. Yoshimine,T.,Hayakawa,T. &Mogami,H. (1988) [Factors affecting the prognosis of brain tumours.]Gan To Kagaku Ryoho 15, 2022–7.PubMedGoogle Scholar
  459. Yoshimura,K.,Egawa,K. &Ono,T. (1990) [Pro-liferating patterns of basal cell carcinoma — immunohistological study by means of anti-BrdU monoclonal antibody.]Nippon Hifuka Gakkai Zasshi 100, 575–80.PubMedGoogle Scholar
  460. Yoshinouchi,M. (1989) [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67.]Nippon Gan Chiryo Gakkai Shi 24, 2513–21.PubMedGoogle Scholar
  461. Yousuf,N.,Khan,S.,Sheikh,Y.,Hyams,D.,Bokhari,J. &Raza,A. (1991a) Cell cycle parameters and DNA ploidy in colorectal carcinomas.J. Surg. Res. 51, 457–62.PubMedCrossRefGoogle Scholar
  462. Yousuf,N.,Yanik,G. A.,George,B. A.,Masterson,M.,Mazewski,C. M.,White,L. M.,Miller,M. A.,Lampkin,B. C. &Raza,A. (1991b) Comparison of two double labelling techniques to measure cell cycle kinetics in myeloid leukaemias.Anticancer Res. 11, 1195–9.PubMedGoogle Scholar
  463. Yu,A. C.,Lee,Y. L. &Eng.,L. F. (1993) Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis.J. Neurosci. Res. 34, 295–303.PubMedCrossRefGoogle Scholar
  464. Zaman-Saroya,S.,Vaughan,F. L. &Bernstein,I.A. (1992) The effect of 2,2′-dichlorodiethyl sulfide on DNA synthesis of a murine stratified keratinocyte culture system.Chem. Biol. Interact. 84, 133–42.PubMedGoogle Scholar
  465. Zarbo,R. J. (1994) Quality control and technical considerations in flow cytometric DNA and cell cycle analysis of solid tumours. InFlow Cytometry and Clinical Diagnosis (edited byKeren,D. F.,Hanson,C. A. &Hurtubise,P. E.). Chicago: Am. Soc. Clinical Pathologists, Inc.Google Scholar
  466. Zarbo,R. J. &Linden,M. D. (1994) DNA analysis of gastrointestinal and genitourinary tract neoplasms. InFlow Cytometry and Clinical Diagnosis (edited byKeren,D. F.,Hanson,C. A. &Hurtubise,P. E.) Chicago: Am. Soc. Clinical Pathologists, Inc.Google Scholar
  467. Zerek-Melen,G.,Pawlikowski,M.,Winczyk,K.,Lachowicz-Ochedalska,A.,Legowska,A.,Kwasny,H.,Przybylski,J. &Szadowska,A. (1993) Effects of new somatostatin analogs on the cell proliferation of colonic crypts and colonic cancers in rats.Neuroptides 25, 57–60.Google Scholar
  468. Zieleniewski,W. (1993) Effect of nilvadipine on adrenocortical cell proliferation and steroidogenesis in early stage of adrenal regeneration.Exp. Toxicol. Pathol. 45, 245–7.PubMedGoogle Scholar
  469. Zwelling,L. A.,Anderson,T. &Kohn,K. W. (1979) DNA-protein and DNA interstrand cross-linking bycis- andtrans-platinum diamminedichloride in L1210 mouse leukaemia and relation to cytotoxicity.Cancer Res. 39, 365–9.PubMedGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • Frank Dolbeare
    • 1
  1. 1.Biology and Biotechnology Program, Lawrence Livermore National LaboratoryUniversity of CaliforniaLivermoreUSA

Personalised recommendations